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ABSTRACT 
Background: Postpartum haemorrhage (PPH) is one of the most preventable causes of 
maternal death, yet it still ranks as one of the main conditions responsible for maternal 
mortality. PPH occurs at a stage when a mother is the least likely to receive care, and 
mothers often do not survive to be referred to a more specialised level of care. This is 
compounded by the patient not being able to warn healthcare providers timeously about 
their condition and healthcare providers lacking training resulting in a lack of accuracy in 
diagnosis, lack of resources, and differing methods of treatment. Due to the lack of 
consensus in available treatment options, and the paucity of research aimed at clinical 
interventions for midwives at the primary care level, this research report aimed to 
investigate the evidence in order to establish the best practices and evidence for clinical 
interventions to manage postpartum haemorrhage for midwives at the primary care level. 
This is to ensure that the continuing education for midwives in practice is based on evidence 
to keep their skill set current and expose practitioners to the latest evidence based care. 
 
Aim: To systematically review all available published evidence for the acute non-
pharmaceutical, non-surgical, management of PPH for use by midwives at a primary 
maternity care setting. 
 
Method: A systematic review of available published evidence was conducted using standard 
systematic review methodology. A detailed search strategy with specific inclusion and 
exclusion criteria based on the PI[C]O was conducted. Literature searches revealed 150 
systematic reviews on the topic, after which a decision was made to perform a review of the 
systematic reviews. Sixteen studies were included for full-text analysis and quality 
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assessment. All included articles were subjected to the AMSTAR-2 quality assessment tool. 
Twelve were excluded, due to being of low or critically low quality. Four reviews were 
included in the analysis. Due to low homogeneity, the results were presented in table 
format and no quantitative synthesis was concluded.  
 
Findings: Although many systematic reviews for the management of postpartum 
haemorrhage exist, they mainly describe the evidence for surgical and pharmaceutical 
interventions which fit within the scope of medical practitioners.  Interventions for 
midwives at the primary care level include nipple stimulation and uterine massage which 
were non-significant. Non-pneumatic anti-shock garments were significant to reduce 
maternal mortality. Self-administered oxytocin was not significant. 
 
Recommendations: It is recommended that further high-quality research is done to 
establish accurate methods to diagnose and treat postpartum haemorrhage for midwives, at 
the primary care level.  
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CHAPTER ONE 
ORIENTATION TO THE STUDY 
1.1.  Introduction 
The aim of this chapter is to set the foundation for the thesis. This chapter includes an 
overview of the literature, purpose, aims and background to the study and a summary of 
the research methodology. This is done in partial fulfilment of a structured Masters in 
Nursing (Nursing Education) by manuscript format. 
 
1.2.  Background to the study 
Postpartum haemorrhage (PPH) is one of the most preventable causes of maternal death, 
yet it still ranks as one of the main conditions responsible for maternal mortality (Ajenifuja 
et al., 2010).  It is one of the major causes of maternal death in South Africa,  and this trend 
is reflected worldwide in varying degrees across both developing and developed countries 
(Ajenifuja, Adepiti, & Oguniyi, 2010; Saving Mothers Report, 2015). PPH can be defined as 
more that 500ml of blood lost from the vagina within 24 hours of delivery (WHO, 2012). 
Severe PPH is defined as a blood loss of more than 1000ml in the same time period (WHO, 
2012). It has serious adverse effects on maternal health. 
 
 In 2015, the 2011 -2013 Saving Mothers Report on maternal deaths in South Africa 
reported that deaths due to obstetric haemorrhage was one of the top three causes of 
maternal mortality in that tri-ennium. This is unchanged in the 2017 Saving Mothers Report, 
which reports on the years 2014-2016 (Saving Mothers Report, 2017). It was reported that 
30.4% of all maternal deaths during this period were due to obstetric haemorrhage, and it 
was preventable in 89% of all cases (Saving Mothers Report, 2015; Saving Mothers Report, 
http://etd.uwc.ac.za/
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2017). This report also highlighted that poor clinical assessment was amongst the top health 
provider related errors, and a contributing factor to the issue (Saving Mothers Report, 2015; 
Saving Mothers Report, 2017).  
 
In South Africa, primary maternity care in the public sector is administered at midwife 
obstetric units, by midwives, in settings where there are no operating theatres and referral 
is through emergency services to a secondary or tertiary level of care. It should be viewed 
with concern that the South African Confidential Enquiries in Maternal Deaths Report (2012) 
states that the majority of deaths due to PPH (94.2%) occurred at public hospitals, and that 
about a third of  (30.7%) PPH related deaths were due to inadequately trained doctors or 
nurses, especially at the primary level of care (Saving Mothers Report, 2012). In addition to 
poorly trained personnel, the scope of practice of midwives is limited. Unless a registered 
midwife has a prescribing license, they may not administer any medications, or perform any 
surgeries, with the exception of oxytocin: “7.3 A registered midwife shall, in the case of 
postpartum haemorrhage when a medical practitioner is not available or pending the arrival 
of the medical practitioner, administer not more than 10 units of oxytocin at a time by 
intramuscular injection, but the administration may be repeated at intervals if and when 
necessary”(South African Nursing Council: R 2488, 1990). Midwives may also not perform 
any surgical management of PPH, and the facilities at which they practice in the low-
resource, primary health and maternity care settings, often do not have operating theatres 
attached to them. 
 
Apart from death, PPH can cause adult respiratory distress syndrome, coagulation disorders, 
shock, hysterectomy and subsequent loss of fertility (ACOG, 2017). As bleeding after 
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delivery is expected, women often do not realise the seriousness of their condition until it is 
too late and they do not survive to be referred to another level of care (Nangalia & 
Thaddeus, 2004; Ogunjimi, Ibe & Ikorok, 2012; ACOG, 2017). In addition to a patient not 
being able to warn healthcare providers timeously about their condition and healthcare 
providers lacking training, the situation is compounded by a lack of accuracy in diagnosis, 
lack of resources, and differing methods of treatment (Lombaard & Pattinson, 2006; 
Ogunjimi, Ibe & Ikorok, 2012).  
 
1.3.  Problem statement 
PPH has been shown to be the major cause of maternal mortality in South Africa (Saving 
Mothers Report, 2012; Saving Mothers Report, 2015; Saving Mothers Report, 2017). PPH 
occurs at a stage when a mother is least likely to receive care. They often do not survive to 
be referred to a more specialised level of care or the seriousness of their condition is not 
identified until they have developed clinical syndromes, resulting in serious morbidity, and 
in most cases, death (Nangalia & Thaddeus, 2004; ACOG, 2017).  
 
Research has shown that the diagnosis and management of PPH is complex, with the 
primary challenge being with the visual assessment of blood loss (Rath, 2011).  Most of the 
primary maternity care in South Africa is provided by midwives, and the overall quality of 
care during the management of PPH is poor (Boltman-Binkowski, 2015). Midwives also have 
a scope of practice which does not enable them to administer or prescribe medications or 
perform any surgeries. These midwives are required to manage this complex clinical 
syndrome using non-pharmaceutical and non-surgical methods. 
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The primary aim of this study was to systematically review and synthesise current evidence 
on the acute non-surgical, non-pharmaceutical management of PPH in order to make 
recommendations on evidence based management of PPH by midwives at the primary 
maternity care level. 
 
1.4.  Significance of the study 
This study may provide evidence-based non pharmaceutical, non-surgical clinical strategies 
for midwives in practice, to use when they are required to manage PPH. In addition, it may 
have an impact on the education of midwives, of new, clinically effective ways to manage 
PPH – both at under and post-graduate level. The methodology used in the study may 
inform nurses and midwives to perform similar studies in their own areas of practice and to 
base their clinical practice on evidence. The results from the study may allow policy-makers 
to review the current midwifery scope of practice to include strategies which are evidence-
based. The study may also reveal gaps and limitations in evidence in order to provide 
further areas for research.  
 
1.5.  Aim 
To systematically review and synthesise all current best practice evidence for the acute non-
pharmaceutical, non-surgical, management of PPH in order to make recommendations on 
non-surgical, non-pharmaceutical management of PPH by midwives at the primary health 
care level. 
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1.6.  Definition of Terms 
Table: Definition of Terms  
Term Definition Operational Definition (In this study) 
Best Practice A set of systematically developed and researched 
statements which inform and shape clinical practice (Nelson, 
2014) 
Best practices refer to clinical practices which 
have been informed by systematic evaluated 
research evidence. 
High resources setting High resource setting can be defined as an area where 
there is no financial hindrance to accessing healthcare 
(facilities, infrastructure, medications, trained personnel or 
equipment), either on a personal or societal level. It is the 
converse of the definition of a low-resource setting (Moahi, 
Bwalya & Sebina, 2017) 
A setting where there are no financial barriers 
on a societal level to accessing essential 
maternity care. 
Low resource setting A healthcare delivery area where a lack of finances lead to 
limited access to facilities, medications, trained personnel, 
infrastructure and equipment. This lack of finances may be 
individual or societal (Moahi, Bwalya & Sebina, 2017) 
Limited access to healthcare due to societal 
lack of finances – leading to limited access to 
resources essential to deliver and receive 
essential maternity care. 
Postpartum 
haemorrhage 
According to the WHO, PPH is defined as a loss of more 
than 500ml of blood per vagina, within 24 hours of delivery. 
Severe PPH is defined as 1 litre or more of blood loss within 
24 hours of delivery (WHO, 2012) 
General definition of PPH will be applied, 
regardless of mode of delivery 
Primary maternity care 
settings 
Primary health care is defined as a set of principles 
underlying the health care system which ensures that basic 
healthcare is accessible by all members of the population 
(WHO World Health Report, 2008) 
Clinical settings where obstetric healthcare is 
delivered in the community, within a primary 
health care system 
 
 
1.7.  Summary of methodology 
Standard systematic review methodology was applied ensure the scientific quality of the 
review using the guidelines set out in The Preferred Reporting Items for Systematic Reviews 
(PRISMA) checklist (see Appendix D). The stages in completing the review were as follows:   
 
 Stage one- systematic search of the literature:  
A comprehensive search of fifteen databases was done in August 2017, to ensure the 
inclusion of all relevant articles (details of databases and search can be found in Chapter 
Three). This search revealed quite a number of systematic reviews on the management of 
postpartum haemorrhage. Following this, the search terms were refined and restricted to 
systematic reviews. Key terms for the search included synonyms of (postpartum 
haemorrhage Or bleeding after delivery) And (management Or assessment Or medication Or 
http://etd.uwc.ac.za/
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pharmaceuticals Or diagnosis Or prediction test) And (Systematic Review Or Randomized 
controlled trial, quasi-experimental study Or relevant evaluation study) AND  >2007. In 
addition, reference lists of the articles were further searched for literature.  
 
 Stage two – abstract screening: 
In order to reach a complete list of abstracts, the Endnote 7 reference manager software 
was used to identify and delete duplicates and irrelevant data from the search. Titles were 
then examined by the student and supervisor for inclusion, based on specified inclusion and 
exclusion criteria (Table 1.).  The student and supervisor then screened the abstracts for 
selection of systemartic reviews to be included in the review based on the PI[C]OS as 
specified in Table 1. Any disagreements for inclusion between the student and supervisor 
would be referred to a third reviewer. Full-text articles were obtained from the abstracts 
and further examined against the PI[C]OS.  
 
 Stage Three - Quality assessment: 
All included full-text articles were subjected to a quality assessment. The latest version of 
the “A MeaSurement Tool to Assess systematic Reviews” (AMSTAR), the AMSTAR-2 tool was 
used to measure the quality of included reviews. The AMSTAR-2 tool had 16 items, but no 
overall score is allocated, according to the user guide for the AMSTAR-2 tool (Shea, et al; 
2017). Reviews were excluded from the analysis if they were identified as having low or 
critically low levels of quality.  
 
 
 
http://etd.uwc.ac.za/
7 
 
 Stage Four and Five – Data extraction/ Data analysis: 
Data were extracted and entered into an excel sheet for analysis. Data were analysed and 
presented in table format and no quantitative synthesis was conducted.  
 
1.8.  Structure of thesis 
The thesis will be presented in five chapters. Chapter One contains the background, 
problem statement, aim and significance of the study. Chapter Two presents a detailed 
literature review focussing on the available management guidelines as well as the current 
pharmaceutical and surgical management of PPH. Chapter Three explains the methodology, 
as well as quality assessment strategies used in this study. In Chapter Four, the results and 
discussion is presented in manuscript format. Chapter Five outlines the limitations, 
discussions and recommendations for the study.  
 
1.9.  Conclusion 
This chapter has presented an outline of the background and problem statement in this 
study. It has also provided an understanding of the terms which are used throughout the 
study, as well as the possible significance the study may have.  
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CHAPTER TWO 
LITERATURE REVIEW 
2.1.  Introduction 
As the study is a detailed systematic review of the literature, this chapter provides a  
summary of issues related to the management of PPH. There are three parts to this 
literature review: the first provides a context and background to the review, the second 
focuses on current pharmaceutical and surgical management strategies for PPH and the 
third examined all the available management guidelines.  
 
2.2.  Literature Review Methodology 
 
This literature review has been conducted using a systematic search process. Each of the 
sections of this literature review has their own methodology, which will be summarised as 
follows: 
 Context and background:  
Focused searches were done through the World Health Organization online resources, 
Google Scholar, Cochrane, Science Direct and Epistomonikos. Search terms which were used 
were according to what was required for the background, and exclusion criteria did not 
apply.  
 
 Pharmaceutical and surgical management:  
Studies were purposefully selected on the basis of whether they were systematic reviews on 
the pharmaceutical management or an article on the surgical management of postpartum 
haemorrhage. Non-english studies were excluded. Outcomes, participants and comparisons 
http://etd.uwc.ac.za/
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were not focused on, as it was aimed to describe the interventions in this section of the 
literature review.  
 
 Summary of all evidence-based guidelines: 
All the the requirements for a defined PICO could not be met, as this was not a systematic 
review, but the principles of the search process were applied in order for this section of the 
summary review to be methodologically sound. The potential for included studies based on 
conventional criteria would be immense so purposive sampling was applied to obtain clinical 
guidelines used internationally in the management of postpartum haemorrhage (Schreiber 
& Stern 1997; Dixon-Woods, Cavers, Agarwal, et al. 2006).  Studies were purposefully 
selected for review on the basis of whether they were an English language, evidence- based 
clinical guideline on the management of postpartum haemorrhage currently used in clinical 
practice. Clinical guidelines in their nature are usually qualitative, hence motivating for 
qualitative strategies being applied in this review. Comparisons and outcome measures 
were not considered, as guidelines usually do not contain these aspects. 
 
An extensive electronic search was carried out to ensure that all relevant literature was 
included in the review. The initial search was done on the major electronic biomedical 
databases like PubMed, EBSCO, Medline, Google Scholar, Science Direct, Academic Search 
Premier, and the Cochrane Controlled Trials register. The bibliographies of articles were 
consulted to ensure that all the relevant trials were included in the review. Key terms for 
the search included evidence-based guidelines, postpartum haemorrhage, bleeding after 
delivery, management, and clinical protocol. Key words and terms were used in isolation but 
also in combination with each other. Full articles were obtained online when available or 
http://etd.uwc.ac.za/
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ordered through the library facilities of the University of the Western Cape. The study 
selection was undertaken independently by the researcher and the guidelines were included 
only if they met the inclusion criteria. Only seven out of 15 articles detailing clinical 
guidelines met the eligible inclusion criteria. The quality of guidelines were not assessed for 
inclusion, as it was not the purpose of the summary to follow the full systematic review 
process, rather to present a summary of the current practice in a systematic manner.  
 
After the data were extracted from the studies and entered into the data collection sheet, 
common themes were identified, and the results were tabulated, in order to present a 
consensus around the current management options for midwives. Consensus in this 
summary was noted as four or more out of seven studies agreeing on a specific outcome 
(over 50%).  
 
2.3.  Context and background to the study 
 Definition of PPH 2.3.1. 
PPH is defined by the World Health Organization (WHO) as more than 500 ml of blood loss 
per vagina during the first 24 hours after birth (WHO, 2009; Rath, 2011; Kerr & Weeks, 
2016). Severe PPH is defined as more than 1000 ml of blood loss per vagina after birth (Rath, 
2011; Kerr & Weeks, 2016). There is a distinct difference in primary and secondary PPH, with 
primary occurring in the first 24 hours after birth, and secondary PPH occurring from 24 
hours to six weeks after delivery (Kerr & Weeks, 2016). Due to issues with measurement of 
blood loss, the definitions of PPH have recently broadened to include clinical signs and 
symptoms of shock, even though the blood loss is estimated at less than the 500ml (Rath, 
2011; Kerr & Weeks, 2016). The mode of birth is also considered when making a diagnosis of 
http://etd.uwc.ac.za/
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PPH, as caesarean section births are associated with a much higher blood loss than vaginal 
births (Rath, 2011). The intent with this study is to focus on primary PPH (first 24 hours after 
birth), as primary care midwives primarily see birthing mothers for their labour and up to six 
hours after birth (Boltman-Binkowski, 2015).  
 
 PPH and maternal mortality 2.3.2. 
Haemorrhage is the highest cause of maternal death worldwide, with PPH causing 480 000 
reported maternal deaths internationally between 2003 and 2009 (Say, et al; 2014). The 
majority (479 000) of these deaths occur in developing regions with just under half of deaths 
caused by PPH in Sub-Saharan Africa (200 000 deaths) (Say, et al; 2014; Saving Mothers 
Report, 2017).  
 
In South Africa, PPH has consistently ranked as one of the top five causes of reported 
maternal mortality (Saving Mothers Report, 2012; Saving Mothers Report, 2015; Saving 
Mothers Report, 2017). It is important to note that the Enquiry into Maternal Death Reports 
(Saving Mothers Reports) only obtains data from health institutions across South Africa, and 
does not report on maternal deaths outside of institutions. The 7th Enquiry into Maternal 
Death Report has reported that deaths due to obstetric haemorrhage are at 16.9% of the 
total maternal deaths in South Africa, as compared the 15.8% in the previous report (Saving 
Mothers Report, 2017). The 6th Enquiry into Maternal Death Report findings state that in 
South Africa, deaths due obstetric haemorrhage have increased 24.7% from an institutional 
maternal mortality rate of 19.51 per 100000 live births in 2002-2004 to an institutional 
maternal mortality rate of 24.32 per 100000 live births in 2011-2013 (Saving Mothers 
http://etd.uwc.ac.za/
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Report, 2015). This is one of the only causes of maternal deaths which have risen in the 
documented period. 
 
 Causes and risk factors for PPH 2.3.3. 
Causes of PPH are multiple, as this is a complex clinical syndrome. The most obvious cause is 
birth injury to the genital tract, but the most significant cause is uterine atony (Ononge, 
Mirembe, Wandabwa & Campbell, 2016). There are also other causal factors, like 
coagulation failure of the haematological system, which occurs in the end stage of 
untreated hypertensive disorders in pregnancy (Hemolysis, Elevated Liver enzymes, Low 
platelet count Syndrome, or HELLP syndrome) (Ononge, Mirembe, Wandabwa & Campbell, 
2016).  
 
Large, multi-country studies on the risk factors for PPH have revealed that large disparities 
exist between the incidences of PPH in low and high income areas, despite a high rate of 
administration of oxytocic medication in both settings (Sheldon, et al., 2014). Specific risk 
factors for this condition, apart from low income, are associated with age, parity, gestational 
age, induction of labour, and mode of birth - caesarean section (Sheldon,et al., 2014). In 
addition, women with a history of PPH were more likely to experience PPH in a subsequent 
pregnancy (Oberg, Hernandez-Diaz, Palmsten, Almqvist & Bateman, 2014). Overall, a history 
of PPH, caesarean section birth, non-administration of oxytocic medication, low income  
geographic locations, increased parity, primigravidity and multiple pregnancy have been 
shown to be associated with an increased risk of PPH (Ononge, Mirembe, Wandabwa & 
Campbell, 2016). 
 
http://etd.uwc.ac.za/
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 Challenges with Diagnosis and Management of PPH 2.3.4. 
In South Africa, a postpartum mother is discharged from maternity care services six hours 
after a normal vaginal delivery if they are deemed to be in a stable condition, and that, 
amongst others, no active vaginal bleeding is occurring (National Department of Health, 
2015). However, PPH may occur any time within the first 24 hours after delivery (Kerr & 
Weeks, 2016). Furthermore, women have come to see vaginal bleeding after delivery as 
normal and may not have the tools to distinguish initially when the bleeding is a cause for 
concern (Wioski, 2015). They may only become aware of seriousness of the condition when 
they are already in clinical shock, and are least likely to receive care (Fawcus & Moodley, 
2011; Nangalia & Thaddeus, 2004). These patients often do not survive their first contact 
with the primary maternity care clinic, and do not make it to be referred to a secondary 
level of care (Fawcus & Moodley, 2011; Saving Mothers Report, 2017). 
 
At the health care facility during the first six hours after delivery, the mother is often left 
with minimal medical assistance, as the floor plan of the primary care midwife obstetric 
units dictate that postpartum mothers are left at the back of the facility while the midwives 
on duty are caring for women in labour at a different area (Boltman-Binkowski, 2015). PPH 
then occurs silently and with no warning to the healthcare providers (Mathai, Gulmezoglu & 
Hill, 2007). 
 
The diagnosis of PPH should  be based on the visual assessment of this blood loss after 
delivery, however studies indicate that visual assessment of blood loss is inaccurate when 
used as the only diagnostic tool (Larsson et al., 2006; Natrella et al., 2017). There are other 
methods of diagnosing PPH which are more expensive and time-consuming and may not be 
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suitable for use in a primary care facility, for example testing the haematocrit levels or 
adding measurement bags to bedding (Atukunda, et al., 2016 ). 
 
To compound the issue of accurate diagnostic techniques, there is a lack of appropriately 
trained healthcare providers to manage PPH with the National Department of Health 
(NDOH), reporting that 27% of deaths related to obstetric haemorrhage were due to the 
lack of adequately trained personnel (Saving Mothers Report, 2015). It was reported that 
the overall quality of care in the management of PPH by midwives was poor, as basic 
resuscitation measures were only instituted in half of the cases measured, and most 
midwives realised that they were not competent to manage PPH independently (Rousseau, 
et al., 2016). This is concerning as most of the care at primary facilities are led by midwives.  
 
 South African Midwifery Scope of Practice 2.3.5. 
South African midwives have a limited scope of practice. Unless a registered midwife has a 
prescribing license, they may not administer any medications, with the exception of 
oxytocin:  
“7.3 A registered midwife shall, in the case of postpartum haemorrhage when a medical 
practitioner is not available or pending the arrival of the medical practitioner, administer not 
more than 10 units of oxytocin at a time by intramuscular injection, but the administration 
may be repeated at intervals if and when necessary”(South African Nursing Council: R 2488, 
1990). In addition, primary care midwives in South Africa do not perform any surgical 
interventions, and most primary care facilities do not have an operating theatre attached 
the facility (Boltman-Binkowski, 2015).  
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2.4.  Specific Management of Postpartum Haemorrhage 
Management options for postpartum haemorrhage are varied, and an overall review of the 
literature revealed a number of systematic reviews on the topic. They could be grouped 
under pharmaceutical, surgical, and non-pharmaceutical interventions. An overview of the 
surgical and pharmaceutical interventions will be presented, as it was excluded from the 
review – due to the previously explained, limited scope of practice of midwives in South 
Africa. As the non-pharmaceutical interventions are included in the systematic review, they 
will be found in Chapter Three and Four in this study. 
 
2.4.1 Pharmaceutical interventions 
Twenty nine systematic reviews on pharmaceutical interventions were found through the 
literature search. The reviews found on pharmaceutical interventions are classified as 
follows: 
 
Table 1: Pharmaceutical interventions not included in analysis by number 
Management intervention Number of reviews found 
Carbetocin 3 
Misoprostol 14 
Tranexamic Acid 12 
 
Each of the pharmaceutical interventions will be explained: 
 Carbetocin 
This drug composition is a human oxytocin synthetic analogue, with a mechanism of action 
similar to oxytocin and is used in the treatment of PPH following caesarean section. It has a 
longer half-life than oxytocin, and therefore a prolonged pharmaceutical effect (Hasan, 
2018). It can be administered intramuscularly or intravenously (Hasan, 2018). Dosages from 
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20 – 100 μg have been found to be effective (Mannaerts, Van der Veeken, Coppejans & 
Jacquemyn, 2018). 
 
In the three reviews found, findings revealed that carbetocin may be a useful alternative to 
oxytocin, although further studies are warranted.  Jin et al (2016) reported a reduced need 
for additional uterotonics when carbetocin was added to the standard postpartum 
treatment.  Although nausea, vomiting and arterial hypotension were found to be adverse 
effects of oxytocin administration, carbetocin would have been thought to have similar 
effects as an analogue. A recent, albeit small, randomised controlled trial reported a 
possible (but not clinically significant) incidence of lower nausea was found with carbetocin  
(Mannaerts, Van der Veeken, Coppejans & Jacquemyn, 2018). The complete lists of reviews 
on the use of carbetocin are included in Appendix A at the end of the report. 
 
 Misoprostol/Prostaglandins  
Misoprostol is a synthetic prostaglandin, which requires individual mention. It was initially 
used in the treatment of ulcers, due to its action on the smooth muscle. It was then found 
that it has excellent properties to contract the uterus, and is still used in early terminations 
of pregnancy (under 7 weeks gestation). It is also used as an induction agent for post-dates 
pregnancy, and recently has successfully been used in the treatment of PPH. It is available in 
tablet form, in 200 – 400 micrograms per tablet. Dosages of 600 micrograms via rectum 
were shown to be effective in the treatment of PPH (Hofmeyr, Gülmezoglu, Novikova & 
Lawrie, 2013). The reviews show a favourable indication that this drug, because it is not 
heat sensitive and does not require knowledge of injection to administer, may be of use in 
primary maternity settings (Tan, et al., 2016) Although this drug has the potential to be used 
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in primary maternity care facilities, it is not within the midwifery scope of practice to 
dispense these drugs at the time of writing this study. It has been reported that use of 
misoprostol has been associated with fevers due to the effect of the prostaglandins, 
although they did not lead to hospitalisation (Durocher, Bynum, León, Barrera & Winikoff, 
2010). The complete list of reviews on the use of misoprostol are included in appendix A at 
the end of the report. 
 
 Tranexamic Acid 
Tranexamic acid acts on the physiological mechanism of bleeding by utilising plasmin to 
impede the process of the enzymatic breaking down of fibrinogen and fibrin. Tranexamic 
acid reduces mortality rates in women with PPH, regardless of mode of birth, with no 
significant adverse effects (Shakur, et al., 2017). There have been no significant adverse 
effects for the action of tranexamic acid on bleeding (Shakur, et al., 2017). The complete list 
of reviews on the use of tranexamic acid are included in appendix A at the end of the report. 
 
2.4.2 Surgical Interventions 
The literature search revealed thirty two articles which either had management options 
related to the pre and post caesarean care, or specific management interventions. The list of 
articles was included in Appendix B at the end of the study.  
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The articles found on surgical interventions can be categorised as follows: 
Table 2: Number of articles with surgical interventions 
Management intervention Number of articles found 
Uterine compression sutures 3 
Hysterectomy 4 
Pelvic or uterine artery embolisation 10 
Outcomes of surgical management of PPH 6 
Caesarean Section 7 
Anaesthetic management of PPH 2 
 
Articles on the outcomes of the surgical management of PPH did not cover specific surgical 
techniques but looked at the fertility and menstrual outcomes of patients following surgery 
for management of PPH. Articles grouped under caesarean section examined various 
factors: general surgical management, intraoperative cell salvage, as well as the risk of 
emergency peripartum hysterectomy. Anaesthetic management was included in the surgical 
grouping, but did include actual surgical interventions for the management of PPH. Each of 
the actual surgical management interventions (uterine compression sutures, hysterectomy 
and uterine artery embolization) will be explained, as part of this section of the literature 
review.  
 
 Uterine compression sutures  
In 1997, the use of uterine compression sutures was introduced by B-Lynch, and was further 
refined by medical practitioners (Matsubara, Yano, Ohkuchi, Kuwata, Usui  & Suzuki, 2013). This 
practice involves accessing the uterus surgically and inserting a suture in various ways in 
order to ‘tighten’ the uterus, to achieve homeostasis (Matsubara et al., 2013). An incision is 
usually made in the lower uterine segment and a suture is passed through the anterior wall 
of the lower segment, looped around the fundus of the uterus and inserted in the posterior 
wall of lower segment again. This forms a shape which looks like braces, used to hold up 
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pants (Matsubara et al., 2013). It is also the reason this is known as a ‘brace’ suture 
(Matsubara et al., 2013). Advantages of this method are that the uterus remains intact in 
order to maintain fertility after the haemorrhage. Disadvantages of this technique are that 
the uterus must be accessed surgically, through an abdominal incision (Matsubara et al., 
2013), but it has proven to be effective in treating postpartum haemorrhage, especially in 
cases of uterine atony (Matsubara et al., 2013). 
 
 Hysterectomy 
Hysterectomy involves the removal of the uterus, surgically, usually through a lower uterine 
segment incision (de la Cruz et al., 2015). The removal of the ovaries may or may not 
happen simultaneously, depending on the surgeon (de la Cruz et al., 2015). A hysterectomy 
ensures that the area of bleeding is completely removed from the mother, and if adequate 
fluid resuscitation is performed – is a lifesaving procedure (Fawkus and Moodley, 2011). The 
use of hysterectomy as a management intervention for postpartum haemorrhage is more 
than likely a last resort to save the mother’s life, and instituted when all other measure have 
failed – due to complete failure of fertility after the procedure (de la Cruz et al., 2015). The 
primary disadvantage is obviously complete loss of fertility, and hormonal changes which 
may result from the removal of the ovaries (de la Cruz et al., 2015).  
 
 Uterine artery embolization  
This procedure is usually performed by a radiologist who specialises in invasive procedures 
using contrast mediums – an interventional radiologist (Aoki et al., 2018). The radiologist 
uses a catheter to insert micro-particles into the uterine vessels, to occlude the blood supply 
to the uterine body (Aoki et al., 2018). This is done through the femoral or radial artery, and 
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requires the use of special equipment like an ultrasound as well as specialised personnel 
(Aoki et al., 2018). The blood vessels absorb the blockage within 4-6 weeks and blood flow 
to the uterine body is confirmed by Doppler testing (Aoki et al., 2018). It is a uterine- sparing 
technique, but also may be prone to affecting fertilisation if the incorrect vessels are 
blocked, or have no effect on the haemorrhage (Aoki et al., 2018). Severe morbidity as a 
result of uterine necrosis has also been reported with the use of this technique (Pirard et al., 
2002; Poujade, 2013) 
 
2.5.  Available Guidelines on PPH: a summary review 
This section of the literature review will provide a summary of available guidelines, which 
looks at the management of PPH. This will illustrate a consensus of the management options 
available, and also provide an insight to the review.  
 
2.5.1 Consensus areas between guidelines 
 Identifying risk factors and etiology 
Early identification of risk factors enables high-risk mothers to be referred to a higher level 
of care and causal factors for PPH enable the midwife to proceed in managing PPH 
accurately. Only two out of six guidelines documented the anatomy and physiology of the 
uterus. Five out of six presented both the primary and secondary causes of postpartum 
haemorrhage, while four also included the risk factors of this condition. One guideline did 
not mention either causes or risk factors. There is a consensus across guidelines that both 
primary and secondary causes of postpartum haemorrhage, as well as risk factors, are an 
important step in the management of postpartum haemorrhage (Table 3). 
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Table 3: Results – guidelines stating causes and risk factors 
 States Anatomy 
and Physiology 
of the Uterus 
States Primary 
Causes of PPH 
States 
Secondary 
Causes of PPH 
States Risk 
Factors 
ACOG Practice Bulletin, 2006 
(United States) 
No Yes Yes Yes 
Saving Mothers: Essential Steps 
in the Management of Common 
Conditions associated with 
Maternal Mortality, 2007 
(South Africa) 
No Yes Yes No 
Education Material for teachers 
of Midwifery, 2008 
(World Health Organization) 
Yes Yes Yes Yes 
National Women’s Health 
Clinical Guideline, 2009  
(New Zealand) 
No  No  No  No 
Monograph on the Prevention of 
Post Partum Haemorrhage, 2010 
(South Africa) 
No Yes Yes Yes 
FIGO Guidelines, 2012 
(FIGO Safe Motherhood and 
Newborn Health Committee – 
International) 
Yes Yes Yes Yes 
 
 Criteria for diagnosis  
Diagnostic criteria are the basis of clinical decision-making. Six of the seven guidelines 
defined postpartum haemorrhage as blood loss of over 500ml. One did not include a 
definition of PPH. Three guidelines admitted that there are difficulties with visual estimation 
of blood loss, but only one (separately from the ones who mentioned difficulty) provided a 
guide to the estimation of blood loss. Two guidelines also referred to the measurement of 
decrease in haematocrit levels (Table 4). Six guidelines differentiated between primary and 
secondary PPH, while only four mentioned vaginal bleeding after birth compared to 
Caesarean section (Table 4). 
 
 
http://etd.uwc.ac.za/
22 
 
 
 
Table 3: Criteria for diagnosis 
 Blood loss 
over 500ml 
Decrease in 
haematocrit 
Visual Estimation 
of blood loss 
Differentiates 
between 
primary and 
secondary 
PPH 
Differentiates  
between 
bleeding after 
vaginal  
birth and  
Caesarean 
section 
ACOG Practice Bulletin, 
2006 
(United States) 
Yes Yes Yes Yes No 
Mousa & Alfirevic, 2007  
(Cochrane Review) 
 
Yes No Yes Yes Yes 
Saving Mothers: Essential 
Steps in the Management of 
Common Conditions 
associated with Maternal 
Mortality, 2007 
(South Africa) 
No No Yes No No 
Education Material for 
teachers of Midwifery, 2008 
(World Health Organization) 
Yes No Provides 
recommendation 
on how to 
accurately 
estimate blood 
loss 
Yes Yes 
National Women’s Health 
Clinical Guideline, 2009  
(New Zealand) 
Yes No Yes Yes No 
Monograph on the 
Prevention of Post Partum 
Haemorrhage, 2010 
(South Africa) 
Yes No States inaccuracy 
in visual 
estimation 
Yes Yes 
FIGO Guidelines, 2012 
(FIGO Safe Motherhood and 
Newborn Health Committee 
– International) 
Yes  No States inaccuracy 
in visual 
estimation 
Yes Yes 
Score (number of guidelines 
agreed) 
6/7 1/7 4/7 6/7 4/7 
 
 Initial evaluation 
There was a general consensus between the guidelines in the in the initial assessment of a 
patient who has PPH. These steps could be performed by a midwife at the primary level of 
care. All the guidelines agree that visual assessment of the lower genital tract should be 
performed (Table 5 ). Four guidelines agree that a full assessment of the condition should be 
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made, including vital signs, as well as obtaining a blood sample for cross matching in case of 
blood transfusion. 
 
Aspects of management which, in addition to the above, were only mentioned in single 
guidelines were:  administration of oxygen; pueperial sepsis; an ultrasound for retained 
products of conception; and also a clot observation test. 
Table 4: Initial evaluation and further diagnostic steps 
 Initial assessment Visual assessment of 
lower genital tract 
Further diagnostic steps 
ACOG Practice Bulletin, 2006 
(United States) 
- Yes Ultrasonography for 
retained placental products, 
clot observation test 
Mousa & Alfirevic, 2007  
(Cochrane Review) 
 
- Yes - 
Saving Mothers: Essential Steps 
in the Management of Common 
Conditions associated with 
Maternal Mortality, 2007 
(South Africa) 
- Yes Suturing, draw blood for 
crossmatch and fresh 
frozen plasma 
Education Material for teachers 
of Midwifery, 2008 
(World Health Organization) 
Full assessment of the 
condition including vital 
signs  
 
Yes Draw blood for crossmatch 
National Women’s Health 
Clinical Guideline, 2009  
(New Zealand) 
Full assessment of the 
condition including vital 
signs 
Yes Draw blood for crossmatch. 
Only guideline to administer 
oxygen 
Monograph on the Prevention of 
Post Partum Haemorrhage, 2010 
(South Africa) 
Full assessment of the 
condition including vital 
signs 
Yes Draw blood for crossmatch 
FIGO Guidelines, 2012 
(FIGO Safe Motherhood and 
Newborn Health Committee – 
International) 
Full assessment of the 
condition including vital 
signs 
Yes Draw blood for crossmatch 
Score (number of guidelines 
agreed) 
4/7 7/7 Draw blood for crossmatch 
– 5/7 
 
 Initial management steps 
All the initial management steps documented in the guidelines do not require expensive 
equipment, but do require some basic knowledge. Midwives at primary care level would 
easily be able to carry out these steps. Six out of seven guidelines agreed that emptying the 
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bladder was one of the first steps to managing PPH (Table 6 ). Evaluation of uterine tone 
was found to be important (6 out of 7 guidelines), while fundal massage was only found in 
five of seven guidelines. 
Table 5 : Initial management steps 
 Emptying of the 
bladder 
Evaluation of uterine tone Fundal massage 
ACOG Practice Bulletin, 2006 
(United States) 
Yes Yes No 
Mousa & Alfirevic, 2007  
(Cochrane Review) 
 
No No No 
Saving Mothers: Essential Steps in the 
Management of Common Conditions 
associated with Maternal Mortality, 2007 
(South Africa) 
Yes Yes Yes 
Education Material for teachers of 
Midwifery, 2008 
(World Health Organization) 
Yes Yes Yes 
National Women’s Health Clinical 
Guideline, 2009  
(New Zealand) 
Yes Yes Yes 
Monograph on the Prevention of Post 
Partum Haemorrhage, 2010 
(South Africa) 
Yes Yes Yes 
FIGO Guidelines, 2012 
(FIGO Safe Motherhood and Newborn 
Health Committee – International) 
Yes Yes Yes 
Score (number of guidelines agreed) 6/7 agreed 6/7 5/7 
 
 Pharmaceutical Management 
Pharmaceutical management of PPH concentrates on uterotonic pharmaceutical agents. 
They can be administered orally, intravenously (IV) or via intramuscular injection (IMI). Most 
of these drugs are light (ergot alkaloids) or heat-sensitive (oxytocin). There are three first- 
line drug therapies recommended for the treatment of PPH. The therapies include 
intravenous oxytocin, followed by intramuscular injection of an ergot alkaloid, and then 
rectal administration of misoprostol. All seven guidelines agreed on all three first-line 
therapies, but there were some differences in dosages and routes.  Two out of seven 
guidelines differed in term of dosage of oxytocin, but the consensus appeared to be reached 
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above 20 IU of oxytocin in one litre of intravenous fluid (Table 7). The same result was found 
for the administration of ergometrine. All seven guidelines agreed that it should be 
administered intramuscularly, but one guideline specified a lower dosage, while another did 
not specify any dosage. Misoprostol administration was also advocated by all seven 
guidelines , with the dosages varying between 600 and 1000 mcg, per rectum. Only one 
guideline suggested a sublingual administration of misoprostol.  
Table 6: Pharmaceutical management 
 Oxytocin IVI Ergot Alkaloid Misopristol 
ACOG Practice Bulletin, 2006 
(United States) 
Oxytocin 10 – 40 IU IVI one litre 
normal saline 
 
Methylergonovine (ergometrine) 
(IM, 0.2 mg) 
 
Misoprostol (800 – 1000 
micrograms (mcg) rectally) 
Mousa & Alfirevic, 2007  
(Cochrane Review) 
 
Oxytocin IVI– dosage not specified Ergometrine, dosage not 
specified 
Misoprostol, dosage & 
route not specified 
Saving Mothers: Essential Steps 
in the Management of Common 
Conditions associated with 
Maternal Mortality, 2007 
(South Africa) 
Oxytocin 20 IU in one litre IV fluids  Ergometrine 0.5 mg IM Misoprostol 600 mcg 
rectally 
Education Material for teachers of 
Midwifery, 2008 
(World Health Organization) 
Oxytocin 20 IU in one litre IV fluids Ergometrine 0.5 mg IM Misoprostol 800 mcg 
rectally 
National Women’s Health Clinical 
Guideline, 2009  
(New Zealand) 
Oxytocin 20 IU in one litre 
Plasmalyte fluid 
Ergometrine 0.5 mg IM Misoprostol 800 mcg 
rectally 
Monograph on the Prevention of 
Post Partum Haemorrhage, 2010 
(South Africa) 
Oxytocin 20 IU in one litre Ringers 
Lactate fluid 20 IU  
Ergometrine 0.5 mg IM Misoprostol 600 mcg 
rectally 
FIGO Guidelines, 2012 
(FIGO Safe Motherhood and 
Newborn Health Committee – 
International) 
Oxytocin 20 IU IVI one litre normal 
saline 
 
Ergometrine 0.5 mg IM Misopristol 800 mcg 
sublingually 
Score (number of guidelines 
agreed) 
7/7 7/7 7/7 
 
 Further management 
Further non-surgical management strategies varied from administration of prostaglandins, 
which are not commonly available at primary care level, to applying special haemostatic 
compression belts. The management strategy most applicable to primary care was the 
suggestion of a ‘balloon tamponade’, which entailed the insertion of a fluid-filled glove into 
the vagina to ensure uterine contraction through compression of the uterus. 
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2.5.2 Consensus of results of summary of guidelines 
The results of the summary review conclude that current management guidelines for PPH 
contain at least the following factors for consideration: 
• Background knowledge about the risk factors for postpartum haemorrhage as 
well as the primary and secondary causes of postpartum haemorrhage. 
• Diagnostic criteria based on a visual estimation of blood loss of more than 500ml, 
even though this has proven to be inaccurate. In addition, diagnostic criteria 
should differentiate between primary and secondary haemorrhage as well as 
bleeding after normal vaginal delivery compared to post-caesarean section. 
• Initial assessment of the extent and cause of the condition, which would be 
obtained through information from vital signs, assessing the lower genital tract, 
and then further, drawing of a blood sample for crossmatch in case a transfusion 
is required.   
• Management steps which would initially be required are emptying the bladder, 
assessing the uterine tone, and fundal massage. 
• Pharmaceutical management would be focused on three major types of drug 
therapies –intravenous oxytocics (20 IU in one litre of intravenous fluid), ergot 
administration (0,5 mg intramuscularly) followed by misopristol 600 mcg rectally. 
• Further management would depend on the kind of resources that are available in 
the setting, but referral to a higher level of care at this stage is imperative, while 
also maintaining uterine contraction through compression. 
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The results of this summary review show that there are specific management strategies 
which may be helpful for midwives to focus on. The management strategies which were 
presented at the end of the integrative summary include aspects of prevention, assessment, 
acute/initial management and pharmaceutical management steps. According to the South 
African midwifery scope of practice, all of these are relevant, except for the administration 
of pharmaceutical and surgical treatments. The results from the summary review will also 
be used to inform the inclusion and exclusion criteria and PIOS for the systematic review in 
this study. This can be found in Chapter Three and Four in this report.  
 
2.6 Conclusion 
The detailed review of the literature revealed a number of systematic reviews on the 
management of PPH and the decision between the supervisor and student was made to do 
a review of systematic reviews on the non-surgical, non-pharmaceutical management of 
PPH. This can be found in Chapter Three and Four of this study. 
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CHAPTER THREE 
METHODOLOGY 
 
3.1.  Introduction 
This chapter will present the systematic review methodology which was used in this study. 
The search strategy, search process, quality assessment, data extraction and data analysis 
will be outlined. An initial search of the literature revealed a number of systematic reviews 
on postpartum haemorrhage and so it was decided that a review of systematic reviews will 
be conducted.  
 
3.2.  Research Approach/Design 
In this study, a systematic review of reviews of available published evidence was conducted, 
following PRISMA guidelines. Systematic reviews typically fall into two categories, of which 
the aggregative methods have received much scientific attention in the past few years. 
Conventional reviews are usually aggregative and are primarily concerned with synthesising 
certain forms of evidence through the application of scientific strategies such as meta-
analysis, and require clear definition of the research question as well as some similarity 
between the phenomena, so that results can be summarised or pooled. In this study, a 
systematic review of reviews of available published evidence was conducted, following 
PRISMA guidelines. 
 
The methodology followed five stages: a comprehensive literature search, followed by a 
title and abstract screen based on the PI[C]OS, then a detailed quality assessment and finally 
the data extraction and analysis. In order to guide the conduct of a review, two main 
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reporting guidelines are primarily used. The Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses or (PRISMA), is a minimum set of requirements for reporting 
the stages that were completed in the review, while the Quality of Reporting of Meta-
analyses or QUOROM statement is similar (Pussegoda, 2017). In this study, the PRISMA 
guidelines for reporting will be used, as the QUOROM statement was updated to the 
PRISMA guidelines in 2009. PRISMA is thus the minimum set of requirements for reporting 
the stages that were completed in a review. The stages of the review are based on the 
guidelines set out in the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses or PRISMA (Moher, Liberati, Tetzlaff & Altman, 2009).  
 
There are 27 items in the PRISMA checklist (see Appendix D). Item 1-4 of the PRISMA 
guidelines are covered in the previous sections of this study. They require that: the report 
be identified as systematic review, the abstract is a structured summary containing full 
details of the study, and that rationale and objectives for the study are clearly outlined 
(Moher, Liberati, Tetzlaff & Altman, 2009).  
 
Items 5-16 of the PRISMA guideline checklist outline the standards for the methods of the 
study, and are as follows: “protocol and registration, eligibility criteria, information sources, 
search, study selection, data collection process, data items, risk of bias in individual studies, 
summary measures, synthesis of results, risk of bias across studies and additional analyses” 
(Moher, Liberati, Tetzlaff & Altman, 2009). For this study, the research protocol has already 
been passed through the official structures of the University of the Western Cape, and is a 
registered protocol for the purposes of completing this thesis. The eligibility criteria for 
inclusion and exclusion in the study are clearly laid out in this chapter in section 3.3. Review 
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Question/ PI[C]OS. Item 7-16 of the PRISMA reporting guideline will be laid out in the rest of 
this chapter, and will contain detailed explanations of each of the criterion.  
 
3.3.  Review Question/ PI[C]OS 
The following review question arose: 
What are the most effective acute non-pharmaceutical, non-surgical management strategies 
(I) to decrease negative health outcomes (O) for women with PPH (P)? 
 
PRISMA reporting guidelines require a well-defined PICOS for every systematic review. The 
PICOS acronym stands for (P): participant, (I): intervention, (C): control/comparison, (O): 
outcome, (S): study type. PICOS requires that the person, problem or participant be well 
described, the intervention searched for to be formulated, comparison or control to be 
clear, and the outcomes to be stated (Schardt, Adams, Owens et al., 2007). As this was a 
review of systematic reviews, there was no comparison or control, and so the PI[C]OS for 
the study was defined. Following the review question and the results from the literature 
review (see Chapter Two), the following PI[C]OS was applied for this study: 
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Table 7: PI[C]OS Criteria applied 
 Inclusion  Exclusion  
Participants Women with primary PPH post normal 
vaginal delivery 
Women with secondary PPH, women 
with antepartum bleeding, women with 
vaginal bleeding of non-pregnancy 
causes, women with PPH post 
caesarean section delivery 
Intervention Non pharmaceutical management 
steps on the management of PPH, 
initial assessment steps (general 
physical assessment, visual 
assessment of the diagnostic tract, 
further diagnostic steps) of PPH,  
Oxytocic related interventions for PPH,  
only 
Pharmaceutical management 
(tranexamic acid, prostaglandins, 
carbetocin), surgical management 
(uterine compression sutures, 
hysterectomy, uterine artery 
embolization, caesarean section, 
anaesthetic management practices), 
management of third stage of labour  
Outcomes Decreased risk of death 
Decreased adverse effects from blood 
loss such as adult respiratory distress 
syndrome, coagulation disorders, 
shock, hysterectomy and subsequent 
loss of fertility.  
 
Adverse outcomes post-surgical 
intervention for postpartum 
haemorrhage (bleeding, necrosis, 
shock, coagulation disorders).  
Types of study Systematic reviews: reviews with a 
quantitative review process, English 
language 
Reviews without a systematic review 
process, Primary studies, non-english 
language 
 
3.4.  Search strategy 
A comprehensive electronic search was carried out to ensure that all relevant published 
quantitative reviews or primary evaluative studies were included in the review. The initial 
search was done on Google Scholar to revise and finalise the search terms and to identify 
the existence of current systematic reviews addressing components of the review question. 
At least 150 systematic reviews were found, resulting in refining the original study and to 
restrict the study to systematic reviews, excluding primary studies. 
 
The scope of the search was not restricted to South Africa, as there were only 10 systematic 
reviews found on the non-pharmaceutical, non-surgical management of postpartum 
haemorrhage, and not all the primary studies included in these reviews were from South 
Africa. The paucity of evidence led to the inclusion of all the reviews, internationally as well. 
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In addition initial searches revealed that prior to 2007, there were a lack of systematic 
reviews on the management of PPH (Oakley, 2005). The study was thus delineated to the 
inclusion of international studies, from the year 2007 to present.  
 
Key terms for the search included synonyms of (postpartum haemorrhage Or bleeding after 
delivery) And (management Or assessment Or medication Or pharmaceuticals Or diagnosis 
Or prediction test) And (Systematic Review) AND  >2007. Key words and terms were used in 
isolation but also in combination with each other. MeSH terms were also used. The full 
electronic search strategy as well as the dates of the search can be found in Appendix E at 
the end of this report.  
 
Fifteen major databases were searched. The major electronic biomedical databases 
including PubMed, EBSCO, Medline, Science Direct, Academic Search Complete, CINAHL, JBI, 
Science Direct, Global Library of Women’s Medicine, Allied and Complementary Medicine 
Database, British Nursing Index, EMBASE, Sage Journals Online, SCOPUS and the Cochrane 
Controlled Trials register were searched. Epistomonikos was used to confirm the results of 
the search at the end of the search process. All results found in Epistomonikos were also 
found in the initial search. 
 
3.5.  Study selection 
Using the search terms, all possible published paper titles were identified and downloaded 
into a reference manager database (End Note 7). Using the Endnote functionality, the 
programme was used to identify a list of duplicate titles. Each duplicate was manually 
examined, and if an actual duplicate was found, one copy of the duplicate was deleted from 
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Endnote. After duplicates were deleted, a full title list was downloaded from Endnote into 
Excel. Titles of papers were classified as irrelevant if they did not include PPH or PPH-related 
topics. All irrelevant titles were manually removed from the Excel sheet at the first stage of 
the selection process. Due to use of the reference management software, the search and 
selection process was able to be documented.  
 
Both reviewers then examined the full title list in the excel sheet, based on the PI[C]OS 
applied in the study (Table 1). Titles were excluded if they did not meet the PI[C]OS and 
categorized with reason for the exclusion. Any discrepancies were resolved by discussion 
between the two reviewers. At the end of this process, a list of included article titles were 
obtained from the excel sheet. The abstracts of all included titles were obtained, using 
Endnote. The abstracts were further examined by both reviewers again, against the PI[C]OS, 
and abstracts which did not meet the PI[C]OS were categorised as excluded, with reasons 
(see Appendix H). The full articles were then obtained, in order to be assessed for quality 
before being included for analysis in the review.  
 
3.6.  Quality Assessment 
All systematic reviews that met the PI[C]OS criteria were evaluated for methodological quality, and 
the AMSTAR-2 tool was used to evaluate methodological quality of the reviews. Inter-rater reliability 
will be assured by two reviewers agreeing on the scientific aspects of the study – from quality 
assessment, inclusion and exclusion of studies to data capturing and analysis (Ten Ham-Baloyi & 
Jordan, 2016). The quality ratings were done by 2 reviewers (student and supervisor). No 
discrepancies for inclusion or exclusion were required to be resolved by referral to a third reviewer.  
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There is an increasing amount of systematic reviews being published in order to support 
healthcare policy and interventions (Shea et al., 2017).  Accepting results from a single 
systematic review without critically examining the manner in which the review was 
conducted poses a risk to the patient if health decisions are based on such reviews. It 
becomes vital to review the manner in which a review was conducted.  
 
An important factor to consider is that a critical appraisal tool is different from a reporting 
guideline. Reporting guidelines are used as a step-by-step process to report the actual 
conduct of the review, while critical appraisal tools are for ensuring the quality of the 
articles which are included in the review. In the literature, five main quality assessment 
tools were revealed to be applied to assess the quality of systematic reviews. Early tools in 
the 1980’s, included the Mulrow and the Sacks criteria, but it was only in 1991 that the first 
validated tool for the assessment of quality of systematic reviews was presented by Oxman 
and Guyat (Pussegoda, 2017). This was known as the Overview of Quality Assessment 
Questionnaire (OQAQ).  
 
In 2007, the “A MeaSurement Tool to Assess systematic Reviews” (AMSTAR) was developed, 
with 10 items. This version of the AMSTAR tool improved on the OQAQ as it addressed new 
quality criteria like examining for sources of bias (Pussegoda, 2017; Shea et al.,2017). 
Subsequent to this, an 11 item version of the AMSTAR, the AMSTAR-R (AMSTAR-Revised) 
was published by a different group of authors to the AMSTAR.   
 
A newer version of the AMSTAR with 16 items (AMSTAR-2) was published in 2017, by the 
same group of authors as the initial AMSTAR. Both the AMSTAR and AMSTAR-2 are 
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acknowledged as validated, reliable tools to assess the quality of systematic reviews. The 
primary difference between the AMSTAR and AMSTAR-2 is that the AMSTAR-2 can be 
applied to systematic reviews which contain randomised controlled trials and those reviews 
which contain non-randomised studies (Shea, et al; 2017). Research acknowledges the 
difficulty in establishing the reliability and validity of the critical appraisal tools (Ten Ham-
Baloyi & Jordan, 2016), and therefore, AMSTAR- 2 was utilised to ensure that quality of the 
included systematic reviews in this study (see Appendix C).   
 
 Quality assessment scores 
The user guide for the AMSTAR-2 maintains that the overall quality assessment should not 
be assigned a score, rather areas of critical and non-critical weakness in the studies should 
be identified. Based on the overall areas of critical and non-critical weakness identified in a 
study, a comprehensive judgement between two reviewers are made on whether or not to 
include the review in the analysis. This also applied to this study. The assessment of quality 
was based on the following explanation: 
Table 8: Quality Assessment Score AMSTAR-2. 
 
Quality Score Explanation 
High 0/1 non-critical weakness 
Moderate More than one non-critical weakness; no critical flaws 
Low One critical flaw with or without non critical weaknesses 
Critically Low More than one critical flaw with or without non-critical weakness 
 
Critical weaknesses were categorised as follows: 
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Table 9: AMSTAR-2 Critical weakness criterion 
 
AMSTAR-2 
Item Number 
AMSTAR-2 Criterion (as stated in Shea, et al (2017)) 
2 Did the report of the review contain an explicit statement that the review methods were established prior to the 
conduct of the review and did the report justify any significant deviations from the protocol? 
4 Did the review authors use a comprehensive literature search strategy? 
7 Did the review authors provide a list of excluded studies and justify the exclusions? 
9 Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that 
were included in the review? 
11 If meta-analysis was performed, did the review authors use appropriate methods for statistical combination of 
results? 
13 Did the review authors account for RoB in primary studies when interpreting/discussing the results of the review? 
15 If they performed quantitative synthesis did the review authors carry out an adequate investigation of publication 
bias (small study bias) and discuss its likely impact on the results of the review? 
 
Non critical weaknesses were categorised as follows: 
Table 10: AMSTAR-2 Non- Critical weakness criterion 
 
AMSTAR-2 
Item 
Number 
AMSTAR-2 Criterion (as stated in Shea, et al (2017)) 
3 Did the review authors explain their selection of the study designs for inclusion in the review? 
5 Did the review authors perform study selection in duplicate? 
6 Did the review authors perform data extraction in duplicate? 
8 Did the review authors describe the included studies in adequate detail? 
10 Did the review authors report on the sources of funding for the studies included in the review? 
12 If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies 
on the results of the meta-analysis or other evidence synthesis? 
14 Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in 
the results of the review? 
 
Quality assessments were completed independently by both reviewers, and the results of 
the assessments were compared for agreement. Based on the criteria set out above, 
reviews were excluded from the study if both reviewers agreed that the quality of the 
review was moderate, low and critically low. 
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3.7.  Data Extraction 
Data were extracted from full text papers only. The data from each publication was 
extracted and entered into an Excel spread sheet. Authors of individual reviews were not 
contacted for further information due to time constraints and the scope of the review being 
for the completion of a mini-thesis research report.  
 
The first stage of data extraction was to identify the individual review characteristics. Study 
characteristics like country, period of data collection, birth setting of review, facility 
characteristics, funding, design of included studies, number of databases searched, grey 
literature searched, number of primary studies included in review, and number of 
randomised controlled trials included in analysis, quality assessment, countries of primary 
studies included in review, recognitions of bias, and limitations of the study were extracted 
per review. This was done to examine whether there would be similarities or differences 
between reviews at this stage, and also to provide a summary of the selection of the 
systematic reviews included in the study.  
 
The second stage of data extraction was to extract detailed information per review, based 
on the inclusion and exclusion criteria and PICO of the reviews. An example of the data 
extraction sheet can be found in Appendix F at the end of this study. 
 
 Data Synthesis 
Systematic reviews typically fall into two categories, of which the aggregative methods have 
received much scientific attention in the past few years (Dixon-Woods, Cavers, Agarwal et 
al. 2006). Conventional reviews are usually aggregative and are primarily concerned with 
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synthesising certain forms of evidence through the application of scientific strategies such 
as meta-analysis, and require clear definition of the research question as well as some 
similarity between the phenomena, so that results can be summarised or pooled. It lends 
itself to the quantitative school of thought (Dixon-Woods, Cavers, Agarwal et al. 2006). This 
method has the limitation that the theory presented in the study cannot be interpreted and 
analysed, giving rise to recent research focusing on interpretative synthesis (Dixon-Woods, 
Cavers, Agarwal et al. 2006). This method is focused on interpreting the theory base of the 
study, and is inductive in nature. It is mainly used to interpret qualitative studies (Dixon-
Woods, Cavers, Agarwal et al. 2006).  
 
For this study, the included data were only presented in table format. The heterogeneity 
between reviews included in this study were high, and homogeneity of the outcome data 
were low. Interventions were not similar- and there were not more than one review per 
intervention, so it was not possible to combine reviews based on intervention or outcome. 
Outcomes were also not similar between reviews (see results Chapter Four). The clinical 
recommendations based on the strength of evidence are also presented.  
 
3.8.  Ethics 
The review protocol was registered by the Senate Higher Degrees Committee of the 
University of the Western Cape. Although ethical approval was applied for, through the 
Human Science Social Science Ethics Committee, as it is a systematic review, the student 
was advised that the study did not have to be approved through this committee. General 
ethical standards on acknowledging and referencing original author guidelines will be 
followed. This is done to treat the original author contributions ethically and fairly (Boddy et 
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al., 2018). All information already in the public domain will be utilised (Boddy et al., 2018). 
This will ensure that the confidentiality of the primary study participants will remain 
confidential.  
 
The scientific rigour of a systematic review also assures that the review is conducted 
ethically. There are various ways to ensure scientific rigour of systematic review, and for this 
review, the PRISMA checklist was closely followed. This was done in order to ensure that 
standards used for writing the review were objective and that the review could be 
replicated again, if following the same steps set out in this review. As there are no human 
subjects or interactions at the core of this study, the principles of beneficence do not apply. 
Although these principles do not apply, care has been taken to approach the research study 
in an ethical manner (Boddy et al., 2018).  
 
3.9.  Conclusion 
In this chapter, the application of the systematic review methodology in this study was 
outlined. The measures to ensure quality of the included reviews were described in detail, 
and the ethical considerations for the review were described. This ensures that the methods 
for this review are scientific, rigorous, and that it was conducted in an ethical manner.  
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CHAPTER FOUR 
RESULTS AND DISCUSSION 
4.1.  Introduction 
The following chapter will present the results and the discussion of the study in manuscript 
format for submission to the African Journal of Nursing and Midwifery using the author 
guidelines. A total of sixteen reviews were found of which four (4) reviews were  
separate reviews and were included. Details can be found in in abstract of article. For ease 
of reading, the manuscript submission (4.2) has been started on a separate page.  
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4.2.  Manuscript for submission 
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Title:  A systematic review of systematic reviews on the non-surgical, non-pharmaceutical 
management of postpartum haemorrhage for primary care midwives 
 
ABSTRACT 
Background:  Postpartum haemorrhage (PPH) is one of the main conditions responsible for 
maternal mortality. Midwives provide most of the maternity care at primary health care level 
and the quality of management of PPH is poor. Although many systematic reviews for the 
management of postpartum haemorrhage exist, they mainly focus on surgical and 
pharmaceutical interventions for medical practitioners. There is a paucity of research on 
clinical nursing interventions for acute PPH for midwives at the primary care level. 
 
Aim: The aim of this study was to systematically review and synthesise current evidence on 
the acute management of PPH in order to make recommendations on non-surgical, non-
pharmaceutical management of PPH by midwives at the primary health care level. 
 
Methods:  A systematic review of reviews of available published evidence was conducted 
using standard PRISMA guidelines. All included reviews were subjected to the AMSTAR-2 
quality assessment tool and a qualitative synthesis of evidence was conducted 
 
Results: A total of sixteen reviews were found of which four (4) reviews were included. 
Interventions for midwives at the primary health care level in these reviews included nipple 
stimulation and uterine massage, both with non-significant results. Non-pneumatic anti-shock 
garments significantly reduced maternal mortality, but self-administered oxytocin was not 
significant. Small study sizes of the primary studies limited the generalizability of the 
findings for this review.  
 
Conclusion:  There is some evidence for the use of pneumatic anti-shock garments, though 
study limitations of existing studies should be taken into consideration. 
 
Recommendations:  Further high-quality research should be done to establish accurate 
methods for the management of PPH for midwives, at the primary care level.  
 
Keywords:  Postpartum haemorrhage; midwives; systematic review 
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INTRODUCTION 
 
Postpartum haemorrhage (PPH) is one of the most preventable causes of maternal death, yet 
it still ranks as one of the main conditions responsible for maternal mortality (Ajenifuja et al. 
2010, 72). PPH can be defined as more that 500ml of blood lost from the vagina within 24 
hours of delivery (WHO, 2012). Severe PPH is defined as a blood loss of more than 1000ml 
in the same time period (WHO, 2012). It has serious adverse effects on maternal health. 
Apart from death, PPH can cause adult respiratory distress syndrome, coagulation disorders, 
shock, hysterectomy and subsequent loss of fertility (ACOG 2017, 169). As bleeding after 
delivery is expected, women often do not realise the seriousness of their condition until it is 
too late (Valdes et al. 2018, 203). Mothers often do not survive to be referred to a more 
specialised level of care (Fawcus and Moodley 2011, 306).  
 
In South Africa, primary health care is administered at midwife obstetric units, by midwives, 
and referral to a higher level of care is through emergency services (Boltman-Binkowski 
2015, 551). In 2015, the 2011 -2013 Saving Mothers Report on maternal deaths in South 
Africa, reported that deaths due to obstetric haemorrhage was one of the top three causes of 
maternal mortality in that tri-ennium (Saving Mothers Report 2015), and has remained 
unchanged since the 2017 Saving Mothers Report(Saving Mothers Report 2017). Nearly a 
third (30.4%) of all maternal deaths during this period was due to obstetric haemorrhage, 
which was preventable in 89% of all cases (Saving Mothers Report 2015, Saving Mothers 
Report 2017). This report highlighted that poor clinical assessment was amongst the top 
health provider related errors, and a contributing factor to maternal deaths (Saving Mothers 
Report 2015, Saving Mothers Report 2017).  
 
 The diagnosis and management of PPH is complex, with the primary challenge being with 
the visual assessment of blood loss (Natrella, et al. 2017).  As women are not able to warn 
healthcare providers timeously about their condition, the situation is compounded by poor 
clinical assessments, a lack of accuracy in diagnosis, lack of resources, and differing methods 
of treatment (Lombaard and Pattinson 2006, Natrella et al., 2017). Most of the primary 
maternity care in South Africa is provided by midwives, and the overall quality of care during 
the management of PPH is poor (Boltman-Binkowski 2015, 552). And additionally the scope 
of practice of midwives is limited. Unless a registered midwife has a prescribing license, they 
may not administer any medications, with the exception of oxytocin (South African Nursing 
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Council Regulation 2488, 1990). Midwives may also not perform any surgical interventions 
(South African Nursing Council Regulation 2488, 1990).   
 
A number of systematic reviews have been published on the management of PPH, however, 
most of these are focused on the evidence for surgical and pharmaceutical interventions for 
medical practitioners. Midwives are required to manage this complex clinical syndrome using 
mainly non-pharmaceutical and non-surgical methods and may find the pharmacology or 
surgeries to be unusable, and not applicable to their scope of practice or to the resources 
available to them.  
 
The aim of this study was therefore to systematically review all available published evidence 
for the acute non-pharmaceutical, non-surgical, management of PPH for use by midwives at a 
primary maternity care setting. On initial searches, a number of systematic reviews were 
identified and the aim was revised to conduct a systematic review of systematic reviews to 
address the review question: What are the most effective non-pharmaceutical, non-surgical 
acute management strategies (I) to decrease negative health outcomes (O) for women with 
PPH (P)? 
 
 
RESEARCH METHODS AND DESIGN 
 
The systematic review of systematic reviews was conducted using standard systematic review 
methodology using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines (Moher Liberati Tetzlaff and Altman 2009) ( Figure 1) 
 
Search strategy 
A comprehensive electronic search was conducted using the major electronic biomedical 
databases, namely PubMed, EBSCO, Medline, Google Scholar, Science Direct, Academic 
Search Premier, CINAHL, Global Library of Women’s Medicine, Science Direct, SAGE, 
Joanna Briggs Institute, British Nursing Index, EMBASE, SCOPUS, Allied and 
Complementary Medicine database and the Cochrane Controlled Trials register were 
searched. The bibliographies of reviews were consulted to ensure that all the relevant reviews 
were included in the review.  
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PRISMA reporting guidelines require a well-defined PICOS for every systematic review, 
namely.(P):  participant (women with primary PPH), (I):  intervention (non-pharmaceutical 
non-surgical acute midwifery interventions), (C):  control/comparison (n/a), (O):  outcome 
(outcomes related to PPH), (S):  study type (systematic review), defining the inclusion and 
exclusion criteria (Table 1). Key terms for the search included synonyms of (postpartum 
haemorrhage Or bleeding after delivery) And (management Or assessment Or medication Or 
pharmaceuticals Or diagnosis Or prediction test) And (Systematic Review) AND >2007. Key 
words and terms were used in isolation but also in combination with each other. On 
completion of the search, the same terms were entered in the Epistomonikos database in order 
to confirm whether there were any outstanding systematic reviews.  
 
Table 1:  Inclusion/Exclusion - (P):  participant, (I):  intervention, (C):  control/comparison, 
(O):  outcome, (S):  study type. 
 Inclusion  Exclusion  
Participants Women with primary PPH post normal 
vaginal delivery 
Women with secondary PPH, women 
with antepartum bleeding, women with 
vaginal bleeding of non-pregnancy 
causes, women with PPH post 
caesarean section delivery 
Intervention Non pharmaceutical management 
steps on the management of PPH, 
initial assessment steps (general 
physical assessment, visual 
assessment of the diagnostic tract, 
further diagnostic steps) of PPH,  
Oxytocic related interventions for PPH,  
only 
Pharmaceutical management 
(tranexamic acid, prostaglandins, 
carbetocin), surgical management 
(uterine compression sutures, 
hysterectomy, uterine artery 
embolization, caesarean section, 
anaesthetic management practices), 
management of third stage of labour  
Outcomes Decreased risk of death 
Decreased adverse effects from blood 
loss such as adult respiratory distress 
syndrome, coagulation disorders, 
shock, hysterectomy and subsequent 
loss of fertility.  
 
Adverse outcomes post-surgical 
intervention for postpartum 
haemorrhage (bleeding, necrosis, 
shock, coagulation disorders).  
Types of study Systematic reviews:  reviews with a 
quantitative review process, English 
language 
Reviews without a systematic review 
process, Primary studies, non-english 
language 
 
Study selection 
All reviews identified during the search were downloaded in to a reference manager (Endnote 
7). Firstly, all duplicates and irrelevant papers from the initial search were deleted using the 
duplicate function and an initial title review.  This was followed by a review of all abstracts 
based on the PI[C]OS (Table 1). Lastly full texts were extracted for all selected abstracts and 
abstracts that were unclear and after application of the PI[C]OS, a final set of reviews were 
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selected for quality assessment. Review of abstracts and full texts were conducted by two 
reviewers and disagreements were discussed and resolved (Figure 1). Only reviews already in 
the public sphere was utilised, and authors of reviews were not contacted for further details.    
 
Quality Assessment 
The selected reviews were assessed for quality using the latest version of the AMSTAR-2 (A 
MeaSurement Tool to Assess systematic Reviews) Reviews were excluded from the analysis 
if they were identified as having a low or critically low level of quality, according to the 
AMSTAR-2 user guide (Shea et al. 2017) (Appendix B).  
 
Data extraction and analysis 
Data were extracted from the reviews and entered into Excel. Due to the heterogeneity of the 
reviews, no quantitative synthesis of the outcome data could be conducted and a qualitative 
synthesis, using a summary table format, was used. Each intervention was also graded 
according to the Oxford Centre for Evidence-Based Medicine Level 1-5 (Table 3) (OCEBM 
Working Group 2011). The Oxford Centre has set out five levels of evidence, with level one 
(1) being the strongest and level five (5) the weakest. Level 1 evidence includes systematic 
reviews and randomised controlled trials with narrow confidence intervals, level two 
evidence includes cohort studies and low-quality randomised controlled trials, while level 
five evidence are expert opinion papers.  
 
Ethical considerations 
Ethics clearance for the study was sought from the University of the Western Cape Faculty of 
Community and Health Sciences Higher Degrees Committee and Senate. Patient consent is 
not required in a systematic review of literature. As only documents available online were 
reviewed, informed consent and protection of data are not required. The ethical guidelines for 
a review were maintained. Authors were not contacted for study data, only data in the public 
sphere were used.  
 
RESULTS 
Search and selection 
The initial search revealed 443 papers, of which 150 were systematic reviews. After the 
examination of the titles, 22 duplicates and 394 irrelevant titles were removed (Figure 1) 
resulting in 27 abstracts to be reviewed by both reviewers against the PI[C]OS criteria (Table 
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1), after which a further 11 were excluded (Figure 1) (Supplementary Material: Appendix A).  
The remaining 16 reviews were examined for eligibility against the AMSTAR 2 criteria and 
12 were excluded due to low quality (Supplementary Material: Appendix B), resulting in  
four (4) reviews which were found to be eligible to be included in the study. 
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Characteristics of included studies 
Four (4) reviews were eligible for inclusion in this review, three (3) non-pharmaceutical 
(Abedi et al. 2016, Hofmeyer Abdel Aleem and Abdel Aleem 2013, and Pileggi-Castro et al. 
2015) and one (1) midwifery-applicable pharmaceutical intervention to manage PPH (Pantoja 
et al. 2016). The non-pharmaceutical interventions were nipple stimulation (Abedi et al. 
2016) and uterine massage to prevent PPH (Hofmeyer Abdel Aleem and Abdel Aleem 2013), 
and the use of non- pneumatic anti shock garments as part of the management of PPH 
(Pileggi-Castro et al. 2015). The quality of four included reviews was high, with either one or 
no non-critical weakness as described in the AMSTAR-2 quality assessment tool (Table 2), 
with high levels of evidence for the reported outcomes (Table 3).  
 
Two out of the four systematic reviews contained pooled data, with only one study containing 
meta-analysis of randomised controlled trials and the other containing pooled data of 
randomised controlled trials and observational studies (Table 2). The remaining two reviews 
did not contain enough data to justify a meta-analysis (Table 2). Levels of evidence for 
included studies were high with two studies being at level one and two studies evaluated at 
level two (Table 3).  
 
Two reviews were published in 2016 (Abedi et al. 2016, Pantoja et al. 2016), one in 2015 
(Pileggi-Castro et al. 2015) and the earliest was published in 2013 (Hofmeyer Abdel Aleem 
Abdel Aleem 2013). Three out of the four reviews were Cochrane reviews (Abedi et al. 2016, 
Hofmeyer Abdel Aleem and Abdel Aleem 2013, and Pantoja et al. 2016). Pileggi-Castro et 
al. 2016 was published in BioMed Central. The birth settings for the primary studies within 
the reviews range from high income settings in the United Kingdom (Abedi et al. 2016), to 
primary non-facility birth settings in Ghana (Pantoja et al. 2016). Three reviews (Abedi et al. 
2016 Pileggi-Castro et al. 2015 and Pantoja et al. 2016) noted poor quality primary studies as 
a serious limitation while Hofmeyer Abdel Aleem and Abdel Aleem 2013 concluded a low 
risk of bias for primary studies included in the review.  
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Table 2: Characteristics of included systematic reviews 
SR Characteristics Inclusion/exclusion criteria Participants Intervention Outcome Measurement 
Author: Abedi et al. (2016)   
 
Period: July 2015 
Setting: Hospital (India, US & UK) Community 
(Malawi) 
Studies: Two RCT's  
Quality Assessment: GRADE 
Bias: high in two studies, unclear in two studies 
AMSTAR 2: High, no critical or non-critical weakness 
(no meta-analysis)  
Limitations: poor quality primary studies 
Definition of PPH: Mild to moderate 
vaginal bleeding in excess of 500 ml 
within 24 hours after birth, severe is 
1000ml vaginal blood loss within 24 hours 
of birth 
Incl: RCT, vaginal birth, with nipple 
stimulation vs no treatment OR uterotonic 
OR uterine massage (before or after 
placental birth) 
Exc: not reported 
#N:4608 (4472 in analysis) 
 
Age: unclear median age 
Gravidity: primigravidas (1) 
Gestation:38wks– term, 
singleton 
Mode of birth: Vaginal 
Baseline: 
 BMI: not stated 
 HB: not stated 
Nipple Stimulation 
Nipple stimulation via breastfeeding 
or breast pump or digital stimulation 
immediately after birth  
Duration of treatment: range from 
20 min on breast pump, 15 min of 
digital stimulation, early suckling 
 
I: Nipple stimulation;  C: none 
I: Nipple stimulation; C:oxytocin 
Blood loss measurement:  
 Transparent plastic jugs 
in units of 100ml 
 Physician estimation and 
hematocrit on day 2 post 
birth postpartum 
Author: Hofmeyr, Abdel-Aleem H, Abdel-Aleem MA 
(2013) 
Period: 30 April 2013 
Setting: University hospitals - Egypt and South Africa  
Studies: Two RCT's 
Quality Assessment: Cochrane –GRADE  
Bias: risk of bias was generally low for both included 
studies, except for blinding (performance and detection 
bias), which would be impossible in  this study 
AMSTAR-2: High, no non-critical weakness 
Limitations: Insufficient evidence due to uterotonic 
administration 
Definition of PPH: heavy bleeding within 
24 hours of birth 
Incl: RCT, vaginal birth OR c/section, 
uterine massage commencing after birth 
of baby 
Exc: not reported 
#N: 1491 (652 in analysis) 
 
Age:18 years and older 
Gravidity/parity: not reported 
Gestation: not reported, 
singleton 
Mode of birth: Vaginal  
Baseline: 
 BMI: not stated 
 HB: not stated 
Uterine massage  
Uterine massage before or after 
placental delivery WITH standard 
treatment VS no uterine massage 
with standard treatment 
 
Duration of treatment: every 10 
minutes for 60 minutes after birth 
 
I: Uterine massage; C: No massage 
Blood loss measurement: 
Plastic drape under participant 
Author: Pantoja et al. (2016)  
Period: 12 November 2015 
Setting: Non-facility, Ghana 
Studies: One Cluster randomised controlled trial 
Quality Assessment: Cochrane -GRADE 
Bias: Detailed assessments of bias done, and quality 
of included studied downgraded as a result of risk of 
attrition and recruitment bias 
AMSTAR-2: High, no non-critical weakness 
Limitations: risk of attrition and recruitment bias and 
very serious imprecision 
 
 
Definition of PPH: Blood loss greater 
than 500 ml after vaginal birth 
Incl: RCT, Vaginal birth in non-facility 
birth settings, PPH and administration of 
oxytocin by non-skilled attendants or 
birthing mother 
Excl: Not Reported 
 
 
 
#N: 1570 (888 in analysis) 
 
Age: Not reported 
Gravidity/parity: Not 
reported 
Gestation: Not reported,  
Mode of birth: Vaginal birth 
Baseline: 
 BMI:  not stated 
 HB:  not stated 
 
Self-administration of oxytocin 
Intramuscular injection of oxytocin 
(10IU) in the thigh after birth, using 
a special syringe  (Uniject) which 
enables self-administration VS no 
injection 
 
Duration of treatment: 1 minute, 
immediately after birth 
 
I: oxytocin, C: no treatment 
Blood loss measurement: 
Calibrated drape under 
participant  
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SR Characteristics Inclusion/exclusion criteria Participants Intervention Outcome Measurement 
Author:Pileggi-Castro et al. (2015) 
Period: March 2014 
Setting: Low-income 
Studies: Four pre and post design and one cluster 
randomised controlled trial 
Quality Assessment:  various - dependent on study 
design 
Bias: Low for the included studies 
Limitations: Insufficient evidence 
AMSTAR-2: High, one non-critical weakness 
Definition of PPH: Abnormal bleeding of 
1000ml or more, or any bleeding with 
hypotension or blood transfusion 
Incl: Not Reported 
Excl: Not Reported 
#1274 (1056 in analysis) 
 
Age: not reported 
Gravidity/parity: Pregnant 
Gestation: not reported 
Mode of birth: not reported 
Baseline: 
 BMI: not stated 
 HB: not stated 
 
Non-pneumatic anti shock 
garment (NASG) 
Non-pneumatic anti shock garment 
PLUS standard care  vs standard 
care only 
 
Duration of treatment: not reported 
 
I: NASG, C: Standard care only 
Blood loss measurement: 
Not reported 
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Table 3:  Outcomes and level of evidence per review 
Identifier Outcomes Treatment Control Outcome 
Author:  Abedi et 
al. (2016) 
 Nipple 
Stimulation  
No Treatment  
 
LOE 1  
SR of RCT's:  2 
RCT's included in 
analysis 
Estimated blood loss: 
PPH>500ml. 
ICU Admission 
 
Other maternal morbidities: 
Retained placenta 
Maternal mortality 
Neonatal mortality 
 
 
 
Anaemia 
 
167/2104 (7.9%) 
 
2/2104 (0.09%) 
 
 
2/2104 (0.09%) 
1/2104 (0.04%) 
20/2129 (0.9%) 
 
Nipple 
Stimulation  
N=32, mean(SD)= 
34(4) 
178/2123 (8.4%) 
 
2/2123 (0.9%) 
 
 
2/2123 (0.9%) 
0/2123 (0%) 
19/2142 (0.88%) 
 
Oxytocin 
 
N= 53, mean 
(SD)= 34.4 (4.4) 
z=0.53, p=0.60 (NS)  
 
z=0.01 p=0.99 (NS)  
 
 
p=0.99, z=0.01 (NS) 
z=0.68, p=0.50 (NS) 
z=0.18, p=0.86 (NS) 
 
 
 
z= 0.43, p=067 (NS) 
Author:  
Hofmeyr, Abdel-
Aleem H, Abdel-
Aleem MA (2013) 
 Uterine Massage No Massage  
LOE:  1  
SR of RCT's:  2 
RCT's included in 
analysis 
Estimated blood loss: 500 ml 
or more after trial entry  
Transfusion 
Anaemia  
Other maternal morbidities:   
Placenta delivered more than 
30 min after birth  
 
45/750 (6.2%) 
 
4/735 (11.4%) 
5/191 (2.6%) 
 
9/753 (1.2%) 
30/741 (4.0%) 
 
4/722 (0.55%) 
8/191 (4.2%) 
 
11/736 (1.49%) 
z=0.23, p=0.81 (NS) 
 
z=0.04, p=0.97 (NS) 
z=0.84, p=0.40 (NS) 
 
z=0.54, p=0.59 (NS) 
Author: Pantoja 
et al. (2016) 
 Oxytocin  No treatment  
LOE:  2  
SR of RCT's:  1 
RCT's included in 
analysis, no 
meta-analysis 
Estimated blood loss: 
PPH>500ml  
 
Transfer to a healthcare facility 
Other maternal morbidities:   
Severe maternal morbidity  
Maternal mortality 
Neonatal mortality: Stillbirth   
 
18/682 (2.63%) 
 
10/682 (1.46%) 
 
0/682 (0%) 
0/888 (0%) 
19/682 (2.8%) 
 
49/887 (5.5%) 
 
18/888 (2.02%) 
 
0/888 (0%) 
0/888 (0%) 
18/888 (2.02%) 
 
z=2.731, p=0.0064 (S, 
favours oxytocin)  
z=0.83, p=0.41(NS) 
 
not estimable 
not estimable 
z=0.73, p=0.47 (NS) 
 Author: Pileggi-
Castro et al. 
(2015) 
 Non-pneumatic 
anti shock 
garment 
Standard Care   
 
LOE:  2  
SR of combined 
studies - one 
RCT and 5 
pre/post design 
included. 
Pre-Post Design Studies 
Preventing Transfusion 
 
Other maternal morbidities:   
Preventing severe maternal 
outcomes 
Preventing maternal mortality 
 
Cluster Randomised Trials 
Preventing Transfusion 
Other maternal morbidities:   
Preventing severe maternal 
outcomes 
Preventing maternal mortality 
 
803/1069 (75%) 
 
 
13/764 (1.7%) 
 
46/1274 (3.6%) 
 
 
167/398 (42%) 
 
 
4/403 (0.99%) 
4/405 (0.98%) 
 
623/898 (69%) 
 
 
32/590 (5.4%) 
 
72/1056 (6.8%) 
 
 
168/435 (38.6%) 
 
 
12/465 (2.58%) 
11/475 (2.31%) 
 
z=0.47, p=0.64 (NS) 
 
 
z=3.57, p=0.0004 (S, 
favours NASG) 
z=3.29, p=0.001(S, 
favours NASG) 
 
z=0.98, p=0.33 (NS) 
 
 
z=1.67, p=0.10 (NS) 
z=1.47, p=0.14 (NS) 
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LOE: Level of evidence, SR: Systematic Review, RCT: Randomised Controlled Trial, PPH: 
Postpartum Haemorrhage, ICU: Intensive Care Unit, NASG: Non-pneumatic anti shock 
garment, NS: Not significant, S: Significant 
 
Non-pharmaceutical intervention outcomes 
 
Nipple Stimulation 
One review (Abedi et al. 2016) provided information on nipple stimulation compared with no 
treatment and compared with oxytocin (Table 3). Though the nipple stimulation compared to 
no treatment resulted in a smaller percentage of cases with PPH > 500ml (.8% vs 8.4%), this 
result was not significant (p=0.60). The results on nipple stimulation show that there is 
insufficient evidence to support the use of nipple stimulation as an intervention to reduce the 
incidence of PPH.  
 
Uterine Massage 
One included review (Hofmeyer Abdel Aleem and Abdel Aleem 2013) compared uterine 
massage and standard treatment with no uterine massage. The results of the meta-analysis 
revealed that there was no significant difference (p= 0.81) in blood loss between groups who 
had received uterine massage before or after the delivery of the placenta (6.2% vs 4%.), with 
both groups receiving standard treatment. No statistically significant trends can be reported 
for this review, although positive non-significant trends were shown to favour the massage 
group for the outcome: mean blood loss at 30 minutes (z=2.43, p= 0.015).  
 
Non-pneumatic anti shock garments (NASG) 
One review (Pileggi-Castro et al. 2015) reported on the use of non-pneumatic anti shock 
garments to manage PPH. There were three outcomes reported on in the study:  prevention of 
maternal mortality, prevention of severe maternal outcomes and prevention of blood 
transfusion. Statistically significant trends were shown in the metal-analysis of the pre-post 
design studies, but not in the cluster randomised studies. The reduction in severe maternal 
outcomes (1.7% vs 5.4%) was shown to favour NASG when using NASG as compared to 
standard care (z=3.57, p=0.0004). For prevention of maternal mortality, similar significant 
outcomes were shown in the same group (z=3.29, p=0.001). In the cluster randomised trial 
group, no significant outcomes could be reported (Table 3).  
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Midwifery-applicable Pharmaceutical Interventions 
One systematic review (Pantoja et al. 2016) reported on the use of self-administered oxytocin 
vs no treatment in non-facility birth settings.  Only one randomised controlled trial was 
included in the analysis and due to lack of primary studies, a meta-analysis could not be 
performed. This was the only review who showed a significant trend in the reduction of PPH 
(bleeding above 500ml) (Relative Risk 0.49%, 95% Confidence Interval 0.27- 0.90; 1174 
women) in the oxytocin group, although the quality of the included trial was poor (Table 3).  
 
 
DISCUSSION 
Midwives are also often the first line of contact for women who are seeking maternal health 
care, which places the midwife in a unique position to be able to recognise opportunities for 
resuscitation early (Hamilton, 2005).The results of the review confirm the lack of  evidence-
based interventions for the clinical management of postpartum haemorrhage by midwives at 
primary care level. Nipple stimulation has no significant effect on the reduction of PPH, and 
while there is an indication that uterine massage may assist in the reduction of PPH, the 
statistical trends are also non-significant.  However, the application of non-pneumatic anti-
shock garments may be of value in the management of PPH at the primary health care level 
and self-administered oxytocin could be a valuable tool to assist women at high-risk for PPH, 
to reduce maternal deaths after discharge from a healthcare facility. 
 
Initial assessment and management of the patient (both haemodynamic status and physical 
assessment), as well as administering drug therapy, is vital knowledge for midwives, but a 
factor which may affect the confidence of midwives to diagnose PPH at primary care level is 
that they practise within a system of medical practitioner-led care, and that the literature does 
not have a consistent definition of PPH, nor a reliable method of assessing blood loss 
(Natrella et al. 2017). This is confirmed by the findings in this study that all of the included 
reviews did not agree on a single definition of PPH (Table 2) 
 
Compounding the issue of assessment and diagnosis, is the relatively narrow scope of 
practice of midwives in South Africa. There are not many non-pharmaceutical evidence 
based interventions which show a significant effect in the management of PPH. 
Pharmaceutical interventions other than oxytocin have been proven to have a significant 
effect on the reduction of PPH but midwives are not able to practice within this sphere (South 
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African Nursing Council R2488 1990). It does not, therefore, come as a surprise that PPH 
was rated as one of the top professional anxieties for midwives in clinical practice (Dahlen & 
Caplice, 2014).  
 
It should be noted that the study was limited due to the restriction of reviews in the English 
language. Current work which was published, was of low quality and the sample sizes were 
small. Low sample sizes limit generalizability of the findings, and impact on the quality of 
reporting of the study. The review showed that there are not many high quality clinical 
research studies on midwifery-specific interventions for the management of PPH. 
 
Recommendations from this study are that midwives at a primary care level could benefit 
from having high quality, evidence based interventions to refer to, which defines simple and 
accurate diagnostic criteria, outlines clinical assessment steps, and details initial management 
which is applicable to the setting and scope of practice of a midwife. Equipment as well as 
skills should be updated on a regular basis. In addition, registered nurses who have been out 
of practice for a period of time may find streamlined evidence-based interventions helpful for 
updating themselves. 
 
CONCLUSION 
It is evident from this review that the issues affecting the management of PPH by midwives 
in clinical practice are complex, and there are not many high quality evidence-based 
recommendations which assist midwives to manage postpartum haemorrhage. Studies which 
are published are of low quality, or are not relevant to midwifery-led care. It is a strong 
recommendation from this review that more high quality research is done into the assessment 
and management of this complex (and silent) clinical syndrome in order to lower the maternal 
mortality rates in this area.  
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SUPPLEMENTARY MATERIAL  
APPENDIX A: EXCLUDED STUDIES AFTER ABSTRACT REVIEW 
 TITLE REASON 
1. Diaz, V., Abalos, E., and Carroli, G. (2014). Methods for blood loss estimation after 
vaginal birth. Cochrane Database of Systematic Reviews, (2). 
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010980/abstract 
doi:10.1002/14651858.CD010980 
Protocol only-no data 
available at time of writing 
up review 
2. Gallos Ioannis, D., Williams Helen, M., Price Malcolm, J., Merriel, A., Gee, H., 
Lissauer, D., . . . Coomarasamy, A. (2015). Uterotonic agents for preventing 
postpartum haemorrhage: a network meta-analysis. Cochrane Database of Systematic 
Reviews, (5). http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011689/abstract 
doi:10.1002/14651858.CD011689 
Protocol only-no data 
available at time of writing 
up review 
3. Jackson, K. W., Allbert, J. R., Schemmer, G. K., Elliot, M., Humphrey, A., and Taylor, 
J. (2001). A randomized controlled trial comparing oxytocin administration before and 
after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet 
Gynecol, 185(4), 873-877. 
http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/608/CN-
00374608/frame.html doi:10.1067/mob.2001.117363 
Exclusion based on type of 
study - this is an RCT not a 
systematic review 
4. Kataoka, Y., Yaju, Y., Hiruta, A., Horiuchi, S., and Mori, R. (2015). Homeopathy for 
reducing blood loss in the third stage of labour. Cochrane Database of Systematic 
Reviews, (4). http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011635/abstract 
doi:10.1002/14651858.CD011635 
Protocol only-no data 
available at time of writing 
up review 
5. Kodkany, B. S., and Derman, R. J. (2006). Evidence-based interventions to prevent 
postpartum hemorrhage: Translating research into practice. Int J Gynaecol Obstet, 94 
Suppl 2, S114-115. doi: 10.1016/s0020-7292(06)60002-7 
Keynote speech - exclude 
based on S: no data 
available for inclusion in 
review 
6. Likis, F. E., Sathe, N. A., Morgans, A. K., Hartmann, K. E., Young, J. L., Carlson-
Bremer, D., . . . Andrews, J. (2015). AHRQ Comparative Effectiveness Reviews 
Management of Postpartum Hemorrhage. Rockville (MD): Agency for Healthcare 
Research and Quality (US). 
Intervention not appropriate 
for inclusion: 
pharmaceutical drugs 
midwives cannot administer 
AND surgical interventions 
7. McDonald, S. J., Abbott, J. M., and Higgins, S. P. (2004). Prophylactic ergometrine-
oxytocin versus oxytocin for the third stage of labour. Cochrane Database of 
Systematic Reviews, N.PAG-N.PAG. 
Intervention: management 
of 3rd stage of labour 
excluded 
8. Penn, A. W., Beam, N. K., and Azman, H. (2015). Non-pneumatic anti-shock garment 
(NASG) as a first aid for preventing or reversing hypovolemic shock secondary to 
obstetric hemorrhage. Cochrane Database of Systematic Reviews(5). doi: 
10.1002/14651858.CD011700 
Protocol only-no data 
available at time of writing 
up review 
9. Tuncalp, O., Souza, J. P., and Gulmezoglu, M. (2013). New WHO recommendations 
on prevention and treatment of postpartum hemorrhage. Int J Gynaecol Obstet, 
123(3), 254-256. doi: 10.1016/j.ijgo.2013.06.024 
WHO Guideline - exclude 
based on S: no data 
available for inclusion in 
review 
10. Walraven, G., Wanyonyi, S., and Stones, W. (2008). Management of post-partum 
hemorrhage in low-income countries. Best Practice and Research Clinical Obstetrics 
and Gynaecology, 22(6), 1013-1023. doi: 
https://doi.org/10.1016/j.bpobgyn.2008.08.002 
Systems/policy 
recommendations - exclude 
based on S: no data 
available for inclusion in 
review 
11. Zelop, C. M. (2011). Postpartum hemorrhage: becoming more evidence-based. Obstet 
Gynecol, 117(1), 3-5. doi: 10.1097/AOG.0b 
Comment on another 
article- exclude based on 
S: no data available for 
inclusion in review 
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APPENDIX B: EXCLUDED STUDIES BASED ON AMSTAR2 WITH REASONS 
  Study Quality Score Reason 
1 Chelmow, 2011 CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
 
Five critical and five non-critical flaws were found:  Critical flaws –it was not 
stated that the review methods were set out prior to the study , no list of 
excluded studies with reasons were provided, and risk of bias (RoB) 
assessments for individual studies not included, RoB not included in the 
discussion of results. Also, adequate discussion of publication bias was not 
found in the study.  
Non-critical flaws were:  study selection and data extraction not performed in 
duplicate, sources of funding or conflict of interest, if any, were not revealed, no 
satisfactory discussion of heterogeneity was included in the results for the 
review, and potential sources of conflict of interest were not revealed. 
2 Doumoutchsis, 
Papageorghiou and 
Arulkumaran, 2007 
CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
Two critical and three non-critical flaws were found:  Critical flaws - risk of bias 
(RoB) assessments for individual studies not included, RoB not included in the 
discussion of results. Non critical flaws were:  sources of funding or conflict of 
interest, if any, were not revealed, and no satisfactory discussion of 
heterogeneity was included in the results for the review.  
3 Gizzo, et al., 2013 CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
Six critical and four non-critical flaws were found:  Critical flaws - it was not 
stated that the review methods were set out prior to the study, the authors did 
not use a comprehensive literature search strategy – only four databases were 
used, no list of excluded studies with reasons were provided, and risk of bias 
(RoB) assessments for individual studies not included, RoB not included in the 
discussion of results. Also, adequate discussion of publication bias was not 
found in the study.  
Non critical flaws were:  selection of study designs for inclusion in the review 
were not described, study selection and data extraction not performed in 
duplicate, and no satisfactory discussion of heterogeneity was included in the 
results for the review.  
4 Hancock, Weeks and 
Lavender, 2015 
CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
Two critical and two non-critical flaws found:  risk of bias (RoB) assessments for 
individual studies not included, RoB not included in the discussion of results. 
Non critical flaws were:  sources of funding, if any, were not revealed, and no 
satisfactory discussion of heterogeneity was included in the results for the 
review.  
5 McCormick, Sanghvi, 
Kinzie, McIntosh, 2002 
CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
Six critical and six non-critical flaws were found:  Critical flaws - it was not stated 
that the review methods were set out prior to the study, the authors did not use a 
comprehensive literature search strategy, no list of excluded studies with 
reasons were provided, and risk of bias (RoB) assessments for individual 
studies not included, RoB not included in the discussion of results. Also, 
adequate discussion of publication bias was not found in the study. 
Non-critical flaws were:  research question did not include the components of 
the PICO, authors did not explain their selection of study designs for inclusion in 
the study, study selection and data extraction not performed in duplicate, 
included studies were not described in adequate detail, and no satisfactory 
discussion of heterogeneity was included in the results for the review. 
6 Miller, Martinand Morris, 
2008 
CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
Five critical and five non critical flaws found. Critical flaws were:  The report did 
not contain a statement which stated that the review methods were established 
prior to the review, and thus deviations from the protocol could not be 
established, a list of excluded studies and their reasons for exclusion were not 
found, risk of bias (RoB) assessments for individual studies not included, RoB 
not included in the discussion of results, publication bias not accounted for or 
discussed. Non critical flaws were:  inclusion criteria did not include the PICO, 
study designs for inclusion in the review were not discussed, study selection and 
data extraction not performed in duplicate. No explanation of heterogeneity was 
provided. 
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7 Natrella, et al., 2016 CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
Six critical and six non critical flaws were found:  Critical flaws - it was not stated 
that the review methods were set out prior to the study, no list of excluded 
studies with reasons were provided, and risk of bias (RoB) assessments for 
individual studies not included, sources of funding for the studies included in the 
review not revealed, RoB not included in the discussion of results. Also, 
adequate discussion of publication bias was not found in the study. 
Non-critical flaws were:  research question did not include the components of 
the PICO, authors did not explain their selection of study designs for inclusion in 
the study, study selection and data extraction not performed in duplicate, no 
satisfactory discussion of heterogeneity was included in the results for the 
review, and potential sources of conflict of interest were not declared in this 
review. 
8 Pacagnella, et al., 2013  CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
Four critical flaws and no none-critical flaws were found. The large number of 
critical flaws found, influenced the quality assessment rating. Critical flaws were:  
no list of excluded studies with reasons were provided, and risk of bias (RoB) 
assessments for individual studies not included, RoB not included in the 
discussion of results. Also, adequate discussion of publication bias was not 
found in the study. 
 
9 Roach, Abramovici and 
Tita, 2012 
LOW 1 critical flaw 
with/without non-
critical weaknesses 
One critical and four non-critical flaws found. The critical flaw was:  a satisfactory 
technique for assessing risk of bias (RoB)for individual studies not included. Non 
critical flaws were:  It was not clear whether study selection and data extraction 
was performed in duplicate, and sources of funding and conflicts of interest not 
stated. 
10 Sathe et al., 2016 CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
Three critical flaws were found. They were:  a list of the excluded studies with 
justifications for exlusion were not found, a satisfactory technique for assessing 
risk of bias (RoB)for individual studies not included, and the authos did not 
account for RoB in the discussion of the review.  
11 Sentilhes, et al., 2016 CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
Five critical and four non-critical flaws were found. Critical flaws - it was not 
stated that the review methods were set out prior to the study, no list of excluded 
studies with reasons were provided, and risk of bias (RoB) assessments for 
individual studies not included, RoB not included in the discussion of results. 
Also, adequate discussion of publication bias was not found in the study. 
Non-critical flaws were:  authors did not explain their selection of study designs 
for inclusion in the study, study selection and data extraction not performed in 
duplicate, and no satisfactory discussion of heterogeneity was included in the 
results for the review. 
12 Sloan, Durocher, Alrich, 
Blum, Winikoff, 2010 
CRITICALLY LOW >1 
critical flaw 
with/without non-
critical weaknesses 
Five critical and one non-critical flaws were found. Critical flaws - it was not 
stated that the review methods were set out prior to the study, no list of excluded 
studies with reasons were provided, and risk of bias (RoB) assessments for 
individual studies not included, RoB not included in the discussion of results. 
Also, adequate discussion of publication bias was not found in the study. 
Non-critical flaw was:  no evidence was found that the authors assessed the 
impact of RoB in individual studies on the results of the meta-analysis.  
 
4.3.  Conclusion 
This chapter presented the results and discussion in a manuscript format. The results 
showed that there are very few evidence-based recommendations for midwives to apply in 
their practice. A detailed discussion of the results as well as recommendations can be found 
in Chapter 5 of this study. 
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CHAPTER FIVE  
CONCLUSION AND RECOMMENDATIONS 
5.1.  Introduction 
This chapter will focus on the discussion of the previous results which were presented in 
Chapter Four. It also concludes the thesis by looking at the key findings of the study, 
presenting the recommendations out of the study, the study limitations and the concluding 
remarks. 
 
5.2.  Key findings of the study 
The results of the review conclude that very few evidence-based interventions exist for the 
actual clinical management of postpartum haemorrhage by midwives at primary care level. 
It is not surprising that the maternal mortality trends are unchanged in recent years. Nipple 
stimulation has no effect on the reduction of PPH, and while there is an indication that 
uterine massage may assist in the reduction of PPH, the statistical trends are also non-
significant.  In addition, the application of non-pneumatic anti-shock garments may be of 
value in the management of PPH at the primary maternity care level. Also, self-administered 
oxytocin could be a valuable tool to assist women at high-risk for PPH, to reduce maternal 
deaths after discharge from a healthcare facility. 
 
5.3.  Discussion 
In this study, all four included systematic reviews had a different definition of PPH, and 
three out of four reviews did not report on the method of assessment of blood loss. 
Although PPH is one of the top causes of maternal mortality worldwide, knowledge of risk 
factors and assessment is vital to form part of an ‘early warning’ system of thinking for 
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midwives. This is to combat the perception that bleeding after delivery is part of the delivery 
process, and to prevent delays in the initiation of resuscitation (Nangalia & Thaddeus, 2004; 
Ogunjimi, Ibe & Ikorok, 2012). Midwives are also often the first line of contact for women 
who are seeking maternal health care, which places the midwife in a unique position to be 
able to recognise opportunities for resuscitation early (Hamilton, 2005; Ogunjimi, Ibe & 
Ikorok, 2012). All of these factors contribute to the importance of maintaining a theoretical 
knowledge base of etiology, causes, and risk factors of this condition.  
 
PPH is usually painless and occurs without warning. Monitoring of the haemodynamic status 
of the patient through vital signs, means that the indication of shock will only manifest after 
at least 1000ml of blood is lost. Blood loss between 500-1000 ml usually does not produce 
severe symptoms in a healthy patient (National Department of Health South Africa, 2015). 
This means the clinical practitioner must depend on other clinical signs, most usually the 
visual estimation of blood loss. Although literature has documented this as notoriously 
inaccurate, there are assistive measures to enable midwives to more accurately estimate 
blood loss. These include filling up bottles of water (500ml to 1000ml) with added colouring, 
to bed linen in order to visualise the actual staining that would occur at differing amounts of 
fluid (World Health Organization, 2008). 
 
Initial assessment and management of the patient (both haemodynamic status and physical 
assessment), as well as administering drug therapy, is vital knowledge for midwives, but a 
factor which may affect the confidence of midwives to diagnose PPH at primary care level is 
that they practise within a system of medical practitioner-led care, and that the literature 
does not have a consistent definition of PPH, nor a reliable method of assessing blood loss.  
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Compounding the issue of assessment and diagnosis is the relatively narrow scope of 
practice of midwives in South Africa. There are not many non-pharmaceutical evidence 
based interventions which show a significant effect in the management of PPH. 
Pharmaceutical interventions other than oxytocin have been proven to have a significant 
effect on the reduction of PPH but midwives are not able to practice within this sphere 
(Chelmow, 2011). It does not, therefore, come as a surprise that PPH was rated as one of 
the top professional anxieties for midwives in clinical practice (Dahlen & Caplice, 2014).  
 
5.4.  Recommendations 
The results of this study show that there are no comprehensive, evidence based 
management guidelines aimed at midwives in the primary care setting, a single, simple 
resource for midwives may assist with clarity in management of this condition at a primary 
care level. This will lead to the following recommendations in the various professional areas: 
 
 Education 
The primary area that this thesis sought to address was to provide an evidence based 
guideline to guide the continuing education of midwives in practice. Midwives should be 
given the necessary support in terms of accessibility to online resources, perhaps as part of 
continuous professional development programmes, in order to keep their skill set current, 
and expose clinical practitioners to the latest level of evidence-based care. 
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 Practice 
Clear referral guidelines for patients with PPH should be implemented and established. 
Regular emergency procedure drills should assist midwives at the primary care level with 
maintaining clinical competency to manage obstetric emergencies. Emergency kits 
containing management algorithms as well as basic equipment should be available in the 
post-natal and labour ward areas.  
 
 Policy 
It is recommended that the scope of midwives in primary maternity care be addressed in 
the changing healthcare climate. This is vital to ensure that we have practitioners which are 
enabled by both internal and professional policy to manage and stabilise mothers in critical 
conditions.  
 
 Research 
It is recommended that further high quality evidence-based clinical research be done to 
establish education and clinical practices which are scientific, for midwives. Focus areas for 
research may be, for example, to establish an accurate method of estimating blood loss 
which does not require invasive intervention and can be implemented in low-resource 
setting. Estimation of blood loss and accurately diagnosing the patient’s condition early 
enough may prevent serious maternal morbidity associated with this condition. 
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5.5.  Limitations of the study 
This study was limited, in that it was only able to review clinical guidelines in the English 
language. There was also a lack of good quality clinical evidence published in English. There 
was also a lack of good quality systematic reviews on the topic.  
 
5.6.  Conclusion and concluding remarks 
Midwives do not have much high quality evidence to rely on when trying to treat PPH, and 
their scope of practice is also not favourable to improving maternal health outcomes in the 
management of this condition. Due to the scanty evidence-base, it can be understood that 
the management of PPH is one of the primary sources of clinical anxieties for midwives.  
 
Postpartum haemorrhage is still one of the main causes of maternal mortality. Having 
effective yet simple evidence-based clinical management tools accessible to midwives in 
practice may reduce confusion and increase response times to the management of this 
condition, as midwives are often the first point of contact for many South African women 
seeking maternal health care. Ensuring steps towards evidence-based care for midwives in 
South Africa is an imperative, considering the status of maternal health at present, and its 
implication for Millennium Development Goals. 
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APPENDIX C: AMSTAR 2: a critical appraisal tool for systematic reviews that include 
randomised or non-randomised studies of healthcare interventions, or both 
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from the protocol?  
For Partial Yes: For Yes:      
The authors state that they had a written As for partial yes, plus the protocol   
protocol or guide that included ALL the should be registered and should also   
following: have specified:   
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review question(s) a meta-analysis/synthesis plan,  Partial Yes 
 a search strategy  if appropriate, and  No 
 inclusion/exclusion criteria a plan for investigating causes   
 a risk of bias assessment 
 of heterogeneity   
justification for any deviations 
  
    
   from the protocol   
3. Did the review authors explain their selection of the study designs for inclusion in the review? 
     
For Yes, the review should satisfy ONE of the following:   
 Explanation for including only RCTs     Yes 
 OR Explanation for including only NRSI     No 
 OR Explanation for including both RCTs and NRSI   
4. Did the review authors use a comprehensive literature search strategy?   
      
For Partial Yes (all the following): For Yes, should also have (all the   
  following):   
 searched at least 2 databases  searched the reference lists /  Yes 
 
(relevant to research question)  bibliographies of included  Partial Yes 
provided key word and/or 
 
studies  No 
 search strategy searched trial/study registries   
 justified publication restrictions  included/consulted content   
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  where relevant, searched for   
   grey literature   
  conducted search within 24   
   months of completion of the   
   review   
5. Did the review authors perform study selection in duplicate?   
       
For Yes, either ONE of the following:       
 at least two reviewers independently agreed on selection of eligible studies  Yes 
 
and achieved consensus on which studies to include  No 
OR two reviewers selected a sample of eligible studies and achieved good   
        
agreement (at least 80 percent), with the remainder selected by one 
reviewer.  
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6. Did the review authors perform data extraction in duplicate? 
 
For Yes, either ONE of the following:       
 at least two reviewers achieved consensus on which data to extract from  Yes 
 
included studies      No 
OR two reviewers extracted data from a sample of eligible studies and   
 achieved good agreement (at least 80 percent), with the remainder     
 extracted by one reviewer.       
7. Did the review authors provide a list of excluded studies and justify the exclusions? 
    
For Partial Yes: For Yes, must also have:   
 provided a list of all potentially Justified the exclusion from  Yes 
 relevant studies that were read  the review of each potentially  Partial Yes 
 in full-text form but excluded  relevant study  No 
 from the review       
8. Did the review authors describe the included studies in adequate detail?   
    
For Partial Yes (ALL the following): For Yes, should also have ALL the   
  following:   
 described populations described population in detail  Yes 
 described interventions  described intervention in  Partial Yes 
 described comparators  detail (including doses where  No 
 described outcomes 
 relevant)   
described comparator in detail 
  
 described research designs 
  
 (including doses where        
   relevant)   
   described study’s setting   
  timeframe for follow-up   
 
9. Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) 
in individual studies that were included in the review? 
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For Partial Yes, must have assessed RoB For Yes, must also have assessed RoB   
from  from:  
 
 
 unconcealed allocation, and  allocation sequence that was Yes 
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RoB:   methods used to ascertain Yes 
 from confounding, and 
 
exposures and outcomes, and  Partial Yes 
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   from among multiple  Includes only 
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10. Did the review authors report on the sources of funding for the studies included in the review?   
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Must have reported on the sources of funding for individual studies included 
in the review. Note: Reporting that the reviewers looked for this information 
but it was not reported by study authors also qualifies  
 
Yes 
No 
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11. If meta-analysis was performed did the review authors use appropriate methods for statistical 
combination of results? 
 
RCTs   
For Yes:   
The authors justified combining the data in a meta-analysis  Yes 
AND they used an appropriate weighted technique to combine  No 
study results and adjusted for heterogeneity if present.  No meta-analysis 
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The authors justified combining the data in a meta-analysis  Yes 
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study results, adjusting for heterogeneity if present  No meta-analysis 
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were adjusted for confounding, rather than combining raw data,   
or justified combining raw data when adjusted effect estimates   
were not available   
AND they reported separate summary estimates for RCTs and   
NRSI separately when both were included in the review   
 
12. If meta-analysis was performed, did the review authors assess the potential impact of RoB in 
individual studies on the results of the meta-analysis or other evidence synthesis? 
 
For Yes:   
included only low risk of bias RCTs  Yes 
OR, if the pooled estimate was based on RCTs and/or NRSI at variable  No 
RoB, the authors performed analyses to investigate possible impact of  No meta-analysis 
RoB on summary estimates of effect.  conducted 
 
13.  Did the review authors account for RoB in individual studies when interpreting/ discussing the 
results of the review?   
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included only low risk of bias RCTs  Yes 
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review provided a discussion of the likely impact of RoB on the results   
 
14.  Did the review authors provide a satisfactory explanation for, and discussion of, any 
heterogeneity observed in the results of the review?   
   
For Yes:   
There was no significant heterogeneity in the results 
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on the results of the review   
15. If they performed quantitative synthesis did the review authors carry out an adequate 
investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 
 
For Yes: 
performed graphical or statistical tests for publication bias and discussed Yes  
the likelihood and magnitude of impact of publication bias No  
No meta-analysis  
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funding they received for conducting the review? 
 
For Yes:   
 The authors reported no competing interests OR  Yes 
 The authors described their funding sources and how they managed  No 
 potential conflicts of interest    
 
 
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P,  
Welch V, Kristjansson E, Henry DA. AMSTAR 2: a critical appraisal tool for systematic reviews 
that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 
2017 Sep 21;358:j4008. 
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APPENDIX D: PRISMA GUIDELINE CHECKLIST 
Section/topic  # Checklist item  
Reported 
on page 
#  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or 
both.  
 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and implications of 
key findings; systematic review registration number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is 
already known.  
 
Objectives  4 Provide an explicit statement of questions being addressed 
with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-
up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, 
giving rationale.  
 
Information 
sources  
7 Describe all information sources (e.g., databases with dates 
of coverage, contact with study authors to identify additional 
studies) in the search and date last searched.  
 
Search  8 Present full electronic search strategy for at least one 
database, including any limits used, such that it could be 
repeated.  
 
Study selection  9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
 
Data collection 
process  
10 Describe method of data extraction from reports (e.g., piloted 
forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators.  
 
Data items  11 List and define all variables for which data were sought (e.g., 
PICOS, funding sources) and any assumptions and 
simplifications made.  
 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual 
studies (including specification of whether this was done at 
the study or outcome level), and how this information is to be 
used in any data synthesis.  
 
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, 
difference in means).  
 
Synthesis of 
results  
14 Describe the methods of handling data and combining results 
of studies, if done, including measures of consistency (e.g., I
2
) 
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for each meta-analysis.  
 
Page 1 of 2  
 
 
Section/topic  # Checklist item  
Reported 
on page 
#  
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the 
cumulative evidence (e.g., publication bias, selective reporting 
within studies).  
 
Additional 
analyses  
16 Describe methods of additional analyses (e.g., sensitivity or 
subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, 
and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
 
Study 
characteristics  
18 For each study, present characteristics for which data were 
extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
 
Risk of bias within 
studies  
19 Present data on risk of bias of each study and, if available, 
any outcome level assessment (see item 12).  
 
Results of 
individual studies  
20 For all outcomes considered (benefits or harms), present, for 
each study: (a) simple summary data for each intervention 
group (b) effect estimates and confidence intervals, ideally 
with a forest plot.  
 
Synthesis of 
results  
21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency.  
 
Risk of bias across 
studies  
22 Present results of any assessment of risk of bias across 
studies (see Item 15).  
 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or 
subgroup analyses, meta-regression [see Item 16]).  
 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of 
evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy 
makers).  
 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of 
bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
 
Conclusions  26 Provide a general interpretation of the results in the context of 
other evidence, and implications for future research.  
 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and 
other support (e.g., supply of data); role of funders for the 
systematic review.  
 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses: The PRISMA Statement.  
PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.
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APPENDIX E: ELECTRONIC SEARCH STRATEGY  
Database 
Type of 
Search Search Terms 
No. of 
articles 
Date of 
search Comments/Field Notes 
Google Scholar   Systematic Review AND postpartum hemorrhage OR postpartum 
haemorrhage 
5 16/08/2017 This was done right at the end to see 
whether any articles were missed. At 
page 2, duplicates kept coming up,so I 
was satisfied that the search had reached 
saturation. Five reviews were saved from 
the initial pages. 18 000 results were 
reported 
Pubmed MESH Systematic Review AND postpartum hemorrhage OR postpartum 
haemorrhage 
0 16/08/2017  None  
Pubmed ALL TERMS -
FILTER 
Filtered Filters applied: systematic reviews, meta-analysis, titiles only. Search Terms 
((systematic review[Title]) AND postpartum heamorrhage[Title]) OR 
postpartum hemorrhage[Title]  
61 16/08/2017   None 
Ebsco: Academic Search 
Complete, CINAHL, 
MEDLINE, E- Journals 
  Systematic Review AND postpartum hemorrhage OR postpartum 
haemorrhage 
197 16/08/2017   None 
Ebsco: Academic Search 
Complete, CINAHL, 
MEDLINE, E- Journals 
  Systematic Review AND postpartum hemorrhage AND management 12 all 
included 
in 197 
16/08/2017   None 
Ebsco: Academic Search 
Complete, CINAHL, 
MEDLINE, E- Journals 
  Systematic Review AND postpartum hemorrhage AND assessment all 
included 
in 197 
16/08/2017   None 
Ebsco: Academic Search 
Complete, CINAHL, 
MEDLINE, E- Journals 
  Systematic Review AND postpartum hemorrhage AND pharmaceutical all 
included 
in 197 
16/08/2017   None 
Science Direct Mixed         None 
Cochrane Controlled Trials 
Register 
  postpartum heamorrhage OR postpartum hemorrhage 28 16/08/2017   None 
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Database Type of 
Search 
Search Terms No. of 
articles 
Date of 
search 
Comments/Field Notes 
JBI    postpartum heamorrhage OR postpartum hemorrhage 5 16/08/2017 http://journals.lww.com/jbisrir/pages/result
s.aspx?txtkeywords=postpartum+hemorr
hage, 1 post C/S intervention, 4 non PPH 
(waterbirth, IOL, maternal mortality, 
preterm labour) 
Global Library of Womens 
Medicine (GLOWM) 
 postpartum heamorrhage OR postpartum hemorrhage 23 16/08/2017 no SR's 
Allied and Complementary 
Medicine Database 
  postpartum heamorrhage OR postpartum hemorrhage 13   no SRs relevant for inclusion 
British Nursing Index   no access 0     None 
EMBASE   no access 0     None 
Sage Journals Online   postpartum hemorrhage OR postpartum heamorrhage OR obstetric 
haemorrhage AND systematic review 
144 16/08/2017 limited search  to 2007-2017, 156 not 
systematic reviews, not on PPH. Search 
is saved under login on Sage. One article 
for abstract review, saved in folder on 
laptop not able to export to endnote 
SCOPUS   postpartum hemorrhage OR postpartum heamorrhage OR obstetric 
haemorrhage AND systematic review 
62 16/08/2017 limited search to 2007-2017, review 
articles only,  
Science Direct   postpartum hemorrhage OR postpartum heamorrhage OR obstetric 
haemorrhage AND systematic review 
40 16/08/2017 limited search to 2007-2017, review 
articles only,  
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APPENDIX F:  DATA EXTRACTION SHEETS  
 
Characteristics of Included Studies 
Identifier Study description 
 Country:  
  Period of data collection/enrollment: 
  Birth Setting:  
  Facility characteristics: 
  Funding: 
  Design of included studies:  
  # data bases searched: 
  Gray literature searched:  
  # studies included: 
  # RCT's included in analysis:  
  Instrument to assess scientific quality:  
  Countries:  
  Recognition of bias:  
  Limitations:  
 
 
PICOS across Studies 
 
Identifier Inclusion/exclusion 
criteria 
Participants Intervention Outcomes 
Author: definition of PPH:  Age: Description of 
intervention:  
Estimated blood loss: 
Inclusion criteria:  Gravidity/parity: Groups:   
Exclusion criteria: Gestation at 
birth: 
N at treatment: Transfusion: 
Method of blood loss 
measurement:  
Mode of birth: N at follow-up:  Anemia: 
  BMI: Duration of treatment: Surgical intervention 
required: 
  Baseline HB: timing of treatment: 
delivery 
Length of hospital 
stay: 
  Singleton 
pregnancy: 
Order of treatment: Harms of 
intervention:NR 
  Multiple 
pregnancy: 
Length of follow-up: Other maternal 
morbidities: 
      Maternal mortality:  
      Preterm birth: 
      Neonatal morbidity: 
      Neonatal mortality: 
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  TABLE OF EXCLUDED STUDIES AFTER ABSTRACTS REVIEWED Reason 
1 Diaz, V., Abalos, E., & Carroli, G. (2014). Methods for blood loss estimation after vaginal birth. Cochrane Database of Systematic 
Reviews, (2). http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010980/abstract doi:10.1002/14651858.CD010980 
Protocol only-no data available at time of writing 
up review 
2 Gallos Ioannis, D., Williams Helen, M., Price Malcolm, J., Merriel, A., Gee, H., Lissauer, D., . . . Coomarasamy, A. (2015). 
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database of Systematic Reviews, 
(5). http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011689/abstract doi:10.1002/14651858.CD011689 
Protocol only-no data available at time of writing 
up review 
3 Jackson, K. W., Allbert, J. R., Schemmer, G. K., Elliot, M., Humphrey, A., & Taylor, J. (2001). A randomized controlled trial  
comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet 
Gynecol, 185(4), 873-877. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/608/CN-00374608/frame.html 
doi:10.1067/mob.2001.117363 
Exclusion based on type of study - this is an 
RCT not a systematic review 
4 Kataoka, Y., Yaju, Y., Hiruta, A., Horiuchi, S., & Mori, R. (2015). Homeopathy for reducing blood loss in the third stage of labour. 
Cochrane Database of Systematic Reviews, (4). http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011635/abstract 
doi:10.1002/14651858.CD011635 
Protocol only-no data available at time of writing 
up review 
5 Kodkany, B. S., & Derman, R. J. (2006). Evidence-based interventions to prevent postpartum hemorrhage: Translating research 
into practice. Int J Gynaecol Obstet, 94 Suppl 2, S114-115. doi: 10.1016/s0020-7292(06)60002-7 
Keynote speech - exclude based on S: no data 
available for inclusion in review 
6 Likis, F. E., Sathe, N. A., Morgans, A. K., Hartmann, K. E., Young, J. L., Carlson-Bremer, D., . . . Andrews, J. (2015). AHRQ 
Comparative Effectiveness Reviews Management of Postpartum Hemorrhage. Rockville (MD): Agency for Healthcare Research 
and Quality (US). 
Intervention not appropriate for inclusion: 
pharmaceutical drugs midwives cannot 
administer AND surgical interventions 
7 McDonald, S. J., Abbott, J. M., & Higgins, S. P. (2004). Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of 
labour. Cochrane Database of Systematic Reviews, N.PAG-N.PAG. 
Intervention: management of 3rd stage of labour 
excluded 
8 Penn, A. W., Beam, N. K., & Azman, H. (2015). Non-pneumatic anti-shock garment (NASG) as a first aid for preventing or reversing 
hypovolemic shock secondary to obstetric hemorrhage. Cochrane Database of Systematic Reviews(5). doi: 
10.1002/14651858.CD011700 
Protocol only-no data available at time of writing 
up review 
9 Tuncalp, O., Souza, J. P., & Gulmezoglu, M. (2013). New WHO recommendations on prevention and treatment of postpartum 
hemorrhage. Int J Gynaecol Obstet, 123(3), 254-256. doi: 10.1016/j.ijgo.2013.06.024 
WHO Guideline - exclude based on S: no data 
available for inclusion in review 
10 Walraven, G., Wanyonyi, S., & Stones, W. (2008). Management of post-partum hemorrhage in low-income countries. Best Practice 
& Research Clinical Obstetrics & Gynaecology, 22(6), 1013-1023. doi: https://doi.org/10.1016/j.bpobgyn.2008.08.002 
Systems/policy recommendations - exclude 
based on S: no data available for inclusion in 
review 
11 Zelop, C. M. (2011). Postpartum hemorrhage: becoming more evidence-based. Obstet Gynecol, 117(1), 3-5. doi: 10.1097/AOG.0b Comment on another article- exclude based on 
S: no data available for inclusion in review 
 
APPENDIX G: All excluded articles with reasons 
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